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Abstract
Expanding the Structural Biologist’s Tool Chest by Chemical and Biocompatible
Modification of Peptides: from Characterizing Marine Snail Toxins to OutPHOXIng
Tryptophan
By
Alexander Grigoryan
Advisor: Dr. Laura Juszczak
This dissertation focuses on expanding chemical derivatization methodologies of peptides with the
ultimate goal of studying proteins that are not amenable to traditional high-resolution structural
techniques. The first project, conducted in the laboratory of Dr. Mandë Holford, uses improved synthetic
and chemical derivatization methods to access and characterize peptidic natural products from venomous
marine snails belonging to the family Terebridae. Closely related to Conus snails, the Terebridae also
produce disulfide-rich peptide toxins (teretoxins) that are potent and specific agonists of ion channels and
receptors of the central nervous system. Teretoxins are underexplored relative to Conus toxins, and
represent a yet untapped pool of tools to investigate neuronal targets that are notoriously hard to
characterize, as well as a source of therapeutic candidates for the treatment of neurological conditions.
This work demonstrates both the application of specialized and improved solid phase peptide synthesis
methods, and a strategy for disulfide mapping of teretoxins through the successful synthesis and
structural characterization of the novel toxin Tv1 from Terebra variegata, the first teretoxin to be
structurally characterized.

The second project, conducted in the laboratory of Dr. Laura Juszczak,

focuses on expanding the utility of fluorescence spectroscopy for the study of peptides and proteins by
developing a novel, environment-sensitive fluorophore capable of biocompatible incorporation into
polypeptides. Using the fluorogenic oxidative coupling reaction of 5-hydroxytryptophan and benzylamine
which produces the fluorescent product 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI), a strategy for sitespecific, biocompatible labeling of peptides with this probe is demonstrated. Investigation of PHOXI’s
photophysics shows that it is a potent environment-sensitive probe, making it a valuable addition to the
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privileged class of solvatochromic fluorophores capable of probing protein structure, interactions and
dynamics.
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Chapter 1 - Introduction
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“I believe, anticipate that the chemist of the future who is interested in the structure of proteins […] will
come to rely upon a new structural chemistry, […] and that great progress will be made, through this
technique, in the attack, by chemical methods, on the problems of biology and medicine.”
Linus Pauling, Nobel Lecture (11 December 1954)

1

1.1 Peptides as tools to study proteins
The understanding of protein structure, dynamics and interactions is central to modern structural
1

biology, as underscored by Linus Pauling’s prophetic quote above . In many ways, with the discovery and
continued sophistication of high-resolution spectroscopic, chemical and biochemical techniques for
probing these enigmatic macromolecules, Pauling’s predicted future has arrived. However, the immense
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chemical and structural complexity of proteins continues to challenge even today’s chemists and
spectroscopists.
One way to overcome this complexity is to work with peptides, or mini-proteins, instead. Pauling
2

and Corey used just this tactic when they first described the α-helix and β-sheet as structural motifs ,
which have since been found in innumerable proteins. Peptides as tools for structural investigation of their
larger protein cousins offer many advantages to the experimenter, both as structural analogues of
proteins and as simpler systems amenable to chemical modification.
The conception and development of solid phase peptide synthesis (SPPS) by Merrifield in 1963

3

provided reliable chemical synthetic access to these molecules, and allowed their functionalization with
chemical groups normally absent from biological systems. In terms of structural biology and medicine,
SPPS gave rise to three important advancements: (i) It provided synthetic access to peptidic natural
products, (ii) allowed for the synthesis of “designer” peptides which were used as models to better
understand protein structure and folding, and (iii) made it possible to include non-native reporter moieties
into peptides, which enabled investigation of their structure and interaction by spectroscopic means.
Building on the synthetic access to peptides and versatility of their chemical modification afforded
by SPPS, this work focuses on expanding chemical derivatization methodologies of these molecules with
the ultimate goal of studying protein that are not amenable to traditional high-resolution structural
techniques. In the first part of this research, improved synthetic and chemical derivatization methods are
developed to access and characterize peptidic natural products from venomous marine snails. These
peptides bind ion channels and receptors of the nervous system, which are transmembrane proteins that
are notoriously difficult to investigate by high-resolution techniques such as X-ray crystallography and
nuclear magnetic resonance spectroscopy (NMR). The second part of the work utilizes model peptides to
develop a novel, environment-sensitive fluorophore capable of biocompatible incorporation into
polypeptides, and is applicable to the study of a larger subset of proteins, which may not be amenable to
high-resolution structural methods and can not be adequately described by fluorescence spectroscopy
utilizing intrinsic probes.
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1.2 Marine snail venom peptides as probes of neuronal proteins
Ion channels and receptors are critical components of the nervous system. Characterizing the
structure and function of these proteins not only allows for the development of pharmaceutical agents for
neurological conditions, but also enables the mapping of neural networks, furthering the understanding of
neuroscience as a whole. However, because these proteins are large, consist of multiple subunits, and
span the cellular membrane, the description of their structure and function is extremely difficult using
traditional techniques. Transmembrane proteins have both hydrophilic and hydrophobic surface exposed
domains, making it difficult to find suitable crystallization conditions for X-ray structure determination.
NMR analyses of these molecules are also challenging, often because of the difficulty of obtaining
sufficient quantities of correctly folded protein during recombinant expression. Finally, attempts to
describe their function by gene knockout methods are often inadequate, as deletion of a single gene
coding for particular subunit interrupts the function of a whole subset of ion channels and receptors that
4

contain it, resulting in a complex phenotype .
One way to work around these challenges has been to use binding partners of these ion channels
and receptors. It is possible to glean structural and functional information about these proteins, provided
that the structure of the binding ligand is known, and that a method of tracking its interaction with the
target exists. One source of such binding partners are venom peptides from marine snails of the
superfamily Conoida, which produce a plethora of potent and specific modulators of ion channels and
4

receptors of the nervous system to capture and immobilize their prey .
From a methodology perspective, three main challenges exist in the development of conoidan
peptide toxins for pharmaceutical and neuroscience research: gaining synthetic access, characterizing
their structure, and describing their biological interactions with specific targets of the nervous system.
While the venom glands of these animals are large enough to identify and elucidate the sequence of
peptide toxins of interest using existing methods, chemical synthesis by SPPS is necessary to obtain
sufficient material for structural and functional testing. Furthermore, the high disulfide content and size of
some of these peptides necessitate customization and improvement of existing SPPS methodology. In
the current work, access to larger toxin peptides utilized a number of SPPS improvements such as
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microwave-assisted coupling , use of improved polymer solid support resins with superior swelling
properties, and use of other techniques of preventing on-resin peptide aggregation.
NMR is traditionally used for structure determination of these peptide toxins, but unambiguous
structural assignment often requires isotopic enrichment, making such analyses both time-consuming and
costly. However, owing to the high disulfide content of these peptides, additional structural detail can be
ascertained by determination of disulfide connectivity by complementary chemical methods, thus aiding
NMR structural assignment even without isotopic enrichment. Existing techniques for disulfide mapping of
6

proteins , which require enzymatic digestion followed by mass spectrometric analysis of the resultant
fragments, are not applicable to conoidan toxins because these peptides often have adjacent cysteine
residues and lack sufficient protease cleavage sites. Instead, a technique of partial disulfide reduction
and differential alkylation, followed by tandem mass spectrometry analysis, was adopted for this purpose
in the current work.
Finally, while several techniques for identifying the specific ion channels or receptors that interact
with a particular peptide toxin exist, most are cost-prohibitive and time-consuming, and thus low
7

throughput. The contemporary development of microarray technology , which allows for rapid screening
of thousands of compounds immobilized on a glass slide against their binding partners, promises an
attractive alternative to existing electrophysiology and cell-based assay methods. The strategy envisioned
in the Holford laboratory includes constructing a toxin peptide microarray. Treating the toxin microarray
with Xenopus laveii oocytes coexpressing a fluorescent protein (a description of Xenopus oocyte
8

expression system for functional studies of ion channels can be found here ) and the ion channel or
receptor of interest would enable rapid screening of a large number of toxins against a particular target.
Work focused on developing a heterobifunctional carbohydrate based linker that could be used for sitespecific immobilization of conoidan toxin peptides on a microarray slide without adversely affecting their
function by way of a bioorthogonal and reversible enzymatic coupling reaction was also pursued as part
of this dissertation project. Despite significant progress towards creation of this linker, commercially
available peptide microarray immobilization strategies were pursued instead, therefore this project will not
be discussed in this dissertation.

5	
  

In summary, this work demonstrates both the application of specialized and improved SPPS
methods, and the novel strategy of disulfide mapping of conoidan toxin peptides through the successful
9

synthesis and structural characterization of the novel toxin Tv1 from Terebra variegata .
1.3 Chemical modification of peptides for fluorescence enhancement
The experiences gained through working with conoidan peptides have set the stage for using
peptide chemical modification strategies to move beyond merely ion channels and receptors, and
investigate a larger subset of proteins for which high-resolution structural techniques are either inadequate
or impossible to implement. Complementary to structural techniques such as X-ray crystallography or
NMR, fluorescence spectroscopy has also been used to provide valuable structural, binding, and
10

dynamics data on a variety of biological systems . It does so by measuring light absorption and emission
characteristics of a fluorescent probe, whose singlet excited state is sensitive to the local chemical
environment.
In the context of protein investigations, the intrinsic fluorophore tryptophan (Trp) has been widely
employed as a probe. Using Trp offers a number of advantages: its presence in many proteins allows for
their investigation without any structural perturbation and proteins that lack Trp can be engineered to
include the residue at a desired position by site-directed mutagenesis. However, Trp is far from an ideal
fluorophore: high energy ultraviolet radiation that is required for tryptophan excitation may be damaging to
some proteins, and is less than desirable for biological fluorescence microscopy. Also, while its
fluorescence emission band is sensitive to the local environment, its complex photophysics often
10

preclude meaningful structural interpretation of its fluorescence signal characteristics . Furthermore,
fluorescence analyses of proteins containing multiple Trp residues, or in the presence of exogenous Trp
do not yield structural data because it is impossible to deconvolute signals from individual tryptophans.
Fortunately, the utility of protein fluorescence spectroscopy has been greatly expanded by
employing extrinsic fluorophores. In developing such probes, parallel monumental achievements have
been made in both the rational design and synthesis of fluorophores with desirable photophysical
properties, and in their methods of incorporation into biological molecules. Modern synthetic methods and
powerful calculation techniques allow for rational design of fluorophores with a great variety properties.
Concurrently, a number of protein incorporation methods have been developed, either by reactions with

6	
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12

intrinsic amino acid functional groups , bioorthogonal coupling methods , or incorporation of the
13

fluorophore as an amino acid using amber (TAG) codon suppression techniques . However, continued
development in both areas is required to give access to probes that have both desirable properties and
are amenable to a specific incorporation method.
While there are many probe incorporation strategies, the most desirable, and the most
challenging introduce the fluorophore at a unique site within the target protein, use a short and rigid tether
to do so, and do not otherwise affect the overall structure or append the target protein with exogenous
groups or sequences. This kind of incorporation maximizes the amount of structural information that can
be gained from a fluorescence experiment because the probe is restricted to its surrounding
14

microenvironment in a known orientation . To date, there are only two methods that can meet these
requirements, and neither one is applicable to every protein.
The first is expressed protein ligation (EPL)

15,16

, which allows for bioorthogonal coupling of

peptide thioesters assembled by SPPS with a target protein containing an N-terminal cysteine residue via
a native peptide bond. Since SPPS allows for incorporation of unnatural fluorophores by chemical
methods, EPL can subsequently be used to append the probe bearing peptide onto a recombinantly
synthesized protein. An obvious limitation of EPL is the requirement of a cysteine residue in favorable
position relative to the probe site.
The second method relies on incorporating a fluorophore as its amino acid derivative in response
to an unused stop codon during recombinant protein expression by chemically acylating it onto a modified
17

tRNA . This technique is extremely difficult to implement, often suffers low incorporation yields, results in
truncated recombinant proteins, and is not necessarily compatible with any unnatural amino acids

13-14

.

In the quest to develop a fluorophore that possesses desirable photophysics and is amenable to
site-specific incorporation, this project focuses on exploring the fluorogenic oxidative coupling reaction of
5-hydroxytrytpohan (5HTP) and benzylamine which produces the fluorescent product 2-phenyl-6Hoxazolo[4,5-e]indole (PHOXI) (Figure 1.2).
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Figure 1.2: Oxidative coupling of 5-hydroxytryptophan (5HTP) and benzylamine to produce
2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI)
This reaction was utilized in analytical chemistry investigations for spectrofluorometric
18

determination of neurotransmitters and related metabolites containing the 5-hydroxyindole(5HI) moiety .
More recently, the reaction was also used to cyclize peptides containing 5HTP and a synthetic amino acid
19

with a benzylamine side chain . Although these studies did not focus on using this reaction as means of
fluorescently tagging peptides and proteins, the reaction conditions and the few photophysical properties
of PHOXI they identified prompted this line of inquiry in the current work.
From an incorporation standpoint, the PHOXI producing reaction is reported to be selective for
5HIs, and can be conducted under aqueous mildly oxidative conditions that should not affect other
functional groups present in peptides and proteins. Since there exist straightforward methods for
incorporation of 5HTP into proteins

20

and peptides

21

(namely by selective pressure incorporation during

recombinant expression in tryptophan auxotrophs, and through standard 9-fluorenylmethoxycarbonyl
(Fmoc) SPPS), this chemistry could be subsequently used for site-specific labeling with PHOXI.
Furthermore, since this reaction modifies an existing amino acid side chain, the PHOXI fluorophore would
be located within the biomolecule in a predictable position, attached to the backbone with a single
methylene bridge. This type of incorporation provides a complementary strategy to the inherently difficult
amber codon and EPL based approaches.
From the photophysical properties standpoint, PHOXI was reported to have high brightness
(through a combination of a high quantum yield and extinction coefficient) and emission in the visible
19

range , both desirable properties for a fluorophore reporter tag. While these properties are encouraging,
a more detailed investigation of the photophysics of PHOXI, including its sensitivity to the chemical
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microenvironment, Förster resonance energy transfer (FRET) interaction with intrinsic fluorophores, and
time-resolved fluorescence properties is needed to glean its utility as a probe for biological systems.
The present work uses model peptides containing 5HTP to evaluate the biocompatibility and
selectivity of PHOXI derivatization. While the reaction is selective for 5HTP, it proceeds through a highly
reactive p-quinoneiminemethide intermediate, which is susceptible to capture by endogenous
nucleophiles other than the intended benzylamine, resulting in a number of undesired byproducts.
Optimization of the reaction conditions using model systems allowed for minimization of these sideproducts and a high-performance liquid chromatography (HPLC) purification method was developed to
isolate the PHOXI labeled peptides for spectroscopic and structural studies. The substrate scope of the
reaction was also briefly investigated by using methylamine and ethanolamine in addition to benzylamine.
While methylamine did not produce any fluorescent adducts under the conditions tested, ethanolamine
produced three different products with fluorescence in the visible region, suggesting that a number of
PHOXI analogues can be synthesized by varying the amine nucleophile.
Recombinant synthesis of proteins containing 5HTP was also attempted in hopes of evaluating
the PHOXI derivatization reaction at the protein level. A variation on the selective pressure incorporation
technique using standard Escherichia coli (E. coli) hosts in the presence of glyphosate (an inhibitor of
aromatic amino acid biosynthesis), instead of the traditionally employed auxotrophic hosts was used.
Unfortunately, attempts to synthesize two different 5HTP-containing proteins using two different
expression systems and three bacterial host strains were not met with success. Because recombinant
20

synthesis of 5HTP-containing proteins has already been demonstrated by other groups , this was not
pursued further, and only 5HTP peptides were used to evaluate this chemistry due to commercial
availability and ease of handling.
The spectroscopic properties of PHOXI and PHOXI-labeled model peptides were also extensively
interrogated as part of this project. Absorption, fluorescence excitation and emission, lifetimes, and
quantum yields of PHOXI evaluated in six neat solvents, were found to vary greatly as a function of
solvent polarity. This sensitivity to the environment puts PHOXI in a privileged class of solvatochromic
probes capable of interrogating the peptide/protein microenvironment. Furthermore, PHOXI’s
photophysics are straightforward and show more dependence on general parameters of
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polarity/polarizability, and are less affected by specific solvent interactions that can complicate structural
attribution of spectral data. These findings show that PHOXI’s photophysics are comparable to or better
than those of other solvatochromic probes, such as Prodan

22

23

or Dansyl , that found applications in

biological systems.
As in Pauling’s vision of the future, this dissertation describes the use and chemical modification
of peptides in developing methods for structural, and functional characterization of otherwise intractable
biological systems. This “attack, by chemical methods” was used to describe the structure of toxin
peptides capable of providing valuable insight into the workings of their protein binding partners; and to
use peptides as proving ground to develop an environment-sensitive probe capable of describing an even
larger subsection of proteins by improved fluorescence methods.
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Chapter 2 - Identification and Characterization of Peptide Marine Natural Products
for Pharmaceutical and Neuroscience Applications
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2.1 Toxins from venomous organisms as drug development and research tools
Disulfide-rich venom peptide toxins found in organisms such as scorpions, snails, snakes, spiders
and leeches are potent and specific modulators of biological targets, making them attractive targets for
24

drug development and downstream research applications . In terms of pharmaceutical applications,
25

nature-inspired peptide therapeutics are gaining traction as an alternative to small molecule drugs .
Peptides, although not as bioavailable as small molecule drugs, have advantages of higher target
26

specificity and selectivity, and decreased toxicity . Recent successes in development of peptide
27

28

pharmaceutics, including captopril , and more recently Prialt® , highlight the promise and potential of
these compounds. Furthermore, the extraordinary affinity and specificity of these toxins contributes to
their ability to characterize the structure and function of their biological targets. For instance, conotoxin
GVIA, a Ca

2+

channel agonist, has been used as a tool in over 2000 investigations for probing the
29

molecular features of the nervous system . With the overall diversity of venom-derived disulfide-rich
peptides estimated at well over two million, and with their biological targets ranging from ion channels and
30

receptors, enzymes and growth factors to structural or ligand binding domains of proteins , the potential
of these compounds as therapeutics and research tools is only beginning to be realized.
2.2 Conoida mollusks as a rich source of neuroactive peptides
Venomous marine snails belonging to the superfamily Conoida represent one source of disulfiderich toxin peptides. Conoidan snails are classified into three groups: cones (Conidae), terebrids
(Terebridae), and turrids (Turridae) (Figure2.1). Among these three groups, the venom of cone snails has
attracted the most research interest, particularly driven by the need to glean the pharmacological basis of
human fatalities caused by Conus envenomation.
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Conidae

Turridae

Terebridae

1 cm
500-800

>10,000

300-400

Estimated Species Diversity
2800

50

50

Approximate Number of Toxin Sequences Identified
Figure 2.1: Conoidan species and toxin diversity
Conoida snails are present in tropical waters worldwide, with various species preying on fish
(piscivorous), worms (vermivorous), or mollusks (molluscivorous). These snails are considerably slower
than their prey, and thus had to evolve their arsenal of chemical toxins and methods for their delivery for
31

the past 50 million years . The product of this evolution is a sophisticated envenomation apparatus
(Figure 2.2) consisting of a venom bulb, a long venom duct equipped with radular teeth which act as a
32

hypodermic needle for venom delivery .
While the sophistication of their venom apparatus is already awe inspiring, these snails’ ability to
produce a plethora of peptide neurotoxins with diverse biological targets rivals that of today’s bestequipped combinatorial chemists. In fact, the genes encoding peptide toxins evolve at a much higher rate
33

than housekeeping genes in these snails .

It has been found that these peptide toxins are highly
+

+

effective as tools for manipulating neuronal targets, including sodium (Na ), potassium (K ) and calcium
2+

34

channels (Ca ), noradrenaline transporters, and nicotinic acetylcholine receptors (nAChRs) . It was
hypothesized that myriad conopeptides act in concert on the nervous system of the prey in synergistic
4

“cabals” . The first, dubbed the “lightning-strike cabal”, leads to rapid immobilization of prey by what
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+

amounts to electrocution through slowing Na channel inactivation while simultaneously inhibiting K

+

channels. The second “motor” cabal finishes the job, by using slower acting toxins to deaden neuronal
circuits at the neuromuscular junction, producing a soporific response. Some cone snails also employ a
third “nirvana” cabal, releasing sensory jamming peptides into the water to pacify small schools of fish
before engulfing them with their huge false mouth in a “net” hunting strategy. While it may seem prudent
to question the therapeutic utility of conoidan peptides, since they are supposed to bind to physiologically
relevant targets of the snails’ natural prey (fish, worms or mollusks), these targets have a high degree of
sequence and structural homology to their corresponding human isoforms.

A

B

Figure 2.2: Conoidan Venom Apparatus. (A) Components of the venom apparatus include the venom
bulb, venom duct and salivary gland where toxins are produced, a sheath containing radular teeth that
are used like hypodermic needles to deliver the toxins through the proboscis. (B) A Scanning electron
micrograph close-up of a radular tooth, showing its harpoon-like structure and opening for venom delivery.
Figure reproduced from reference 32.
It is difficult to estimate the vast number of biologically active peptides that can be identified from
Conoida snails. A typical modern venom transcriptome sequencing experiment can identify 50-100 toxin35

encoding genes in a single species . Due to extensive post-translational processing and modification, the
number of mature peptide toxins present in one specimen can be an order of magnitude higher. For
36

example, 2428 peptide masses were identified from the venom of Conus textile . Factors like
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intraspecies, and even intraspecimen venom heterogeneity, inflate the number of putative toxins even
further. Considering that there are about 700 known species of cone snails alone (disregarding turrids
and terebrids), the most conservative estimate is approximately 50,000 toxin sequences at the genetic
level, and over 1,000,000 at the peptide level. Given these numbers, the effort to identify and characterize
these toxins has been vastly lacking in throughput with only 2837 nucleotide toxin sequences identified
from 80 Conus species, and just 175 toxins from 34 Conus species structurally characterized

37

(data from

ConoServer accessed on 5/16/15). It is important to note that the above data represent only the toxin
diversity and identified peptide toxins among Conus species, while the toxins of the Terebridae
(approximately 300-400 species) and the Turridae (up to 10,000 species) remain largely unexplored.
Specifically, this work focuses on the peptides of the Terebridae, an under-investigated sister group of the
cones. While this group was chosen in hopes of identifying peptides with novel structures or targets,
many descriptions of conopeptides, such as their structural and gene organization features, also hold true
for terebrids and serve as a foundation to guide this inquiry.
2.3 Conoidan toxin structure and function: lessons from cone snails
The laboratories of Baldomero (Todo) Olivera, Paul Alewood and Richard Lewis pioneered the
subject of conopeptide research, and in many ways shaped the body of knowledge in the field today
38

24a, 32,

. Early venom fractionation experiments identified two types of peptide components: disulfide poor

(such as contulakins

39

40

and conantokins ) and disulfide-rich, termed conotoxins. These multiply

disulfide-bonded conotoxins are the major component of the venom peptide repertoire of Conus snails,
and target ion channels and receptors with extreme potency and selectivity. To date, conotoxins have
2+

+

+

been found to interact with a variety of neuronal targets, including Ca , Na , K voltage- and ligand-gated
channels, nAChRs, neurotensin receptors, N-methyl-D-aspartate (NMDA) receptors, norepinephrine
41

transporters, and G-protein coupled receptors (GPCRs) . With such diversity of targets, it is not
surprising to see conotoxins as subjects of clinical trials as neuropathic pain analgesics, anti42

43

44

convulsants , anti-cancer agents , and cardioprotectants ; with one conotoxin (MVIA from Conus
28

magus, known as Prialt® or Ziconotide) approved for the treatment of chronic and severe pain .
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Conoidan toxins are single gene products, with messenger RNA (mRNA) translated into a
precursor comprised of a highly conserved signal N-terminal signal sequence, an intervening and
somewhat more variable pre-pro region, and a C-terminal mature toxin sequence (Figure 2.3).

Conserved

Signal Sequence

Moderately Variable

Propeptide

Hypervariable

Mature toxin

Figure 2.3: Conoidan peptide toxin precursor organization
Mature conotoxin peptides, liberated by proteolysis from the signal and pre-pro regions, have a
conserved pattern of cysteine residues and hypervariable intercysteine loops. The typical size of mature
conoidan peptides is 10 to 60 amino acids, with at least 2 and as many as 10 cysteine residues. The
highly conserved signal sequences are used to classify conotoxins into gene superfamilies, the pattern of
cysteine residues into frameworks, and their biological targets into pharmacological families

38b

(Figure

2.4). All mature conotoxins are post-translationally modified to contain disulfide bonds, and some have
been found to contain a number of other post-translational modifications (PTMs), most common of which
are C-terminal amidation, proline hydroxylation, and glutamate γ-carboxylation. Although most of these
PTMs are found in other species, they occur at a higher rate in these short peptides, making extensive
PTM one of the defining features of conotoxins. The significance of PTMs in conotoxins is still being
45

explored, and it has been suggested that they can play either functional or structural roles . The roles of
PTMs are complex and enigmatic, as they may be required for function or for the correct folding of one
conotoxin, while having no effect on the activity or fold of another. It has been hypothesized that PTMs in
cone snails are yet another level of refining their toxins, analogous to drug lead optimization done by
4

pharmaceutical companies .
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Figure 2.4: Classification of conotoxins by gene superfamilies, cysteine frameworks and pharmacological families. Figure reproduced from reference 38b
2.4 The peptide toxins of the Terebridae
Being a sister group of the cones, the Terebridae also express an arsenal of disulfide-rich
conotoxin-like peptides (teretoxins). While there are only a few studies of terebrid venom, it is known that
their toxins arise from mRNA with organization analogous to that of the cones, containing a signal
46

sequence, pre-pro, and mature peptide regions . Interestingly, the signal sequences of the Terebridae
have a low degree of homology to the cones, suggesting that Conus gene superfamilies do not extend to
the Terebridae

46a

. Consistent with this earlier study, a recent report identified 14 terebrid gene

superfamilies, with only one of them having a strong (80%) sequence identity with a conotoxin
47

superfamily (H) . Although it is too early to draw any conclusions given the limited number of studies on
the Terebridae, the disulfide-rich toxins identified so far have been longer (40 amino acids and greater)
29

than Conus sequences, making teretoxins more similar to those of spiders and snakes . While most
conserved cysteine frameworks found in the Terebridae are the same as those found in cones, two novel
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47

frameworks containing 10 and 12 cysteines were recently identified . The greater length of teretoxins
also contributes to greater numbers of residues in the intercysteine loops relative to conotoxins. Yet
another consequence of length is the prevalence eight-cysteine (rare in cones) and the scarcity of fourcysteine frameworks (prevalent in cones) in the toxin peptides of the Terebridae.
The few studies conducted so far suggest that terebrid neuropeptides are free from PTMs, aside
from C-terminal amidation

46

. A recent second generation sequencing analysis of the venom duct

transcriptome of two terebrid species, T. annilis and T. subulata, identified nucleotide sequences
corresponding

to

four

PTM

enzymes

(γ-glutamyl

carboxylase,

peptidyl-glycine-α-amidating

monooxygenase, prolyl-4-hydroxylase, tyrosyl sulfotransferase and glutamyl-peptide cyclotransferase) in
47

the specimens . Although the presence of these enzymes suggests that PTMs cannot be ruled out for
teretoxins, these proteins are quite ubiquitous across other mollusks and even mammals, and are also
implicated in a variety of housekeeping roles. Therefore, the last word on the presence of PTMs in
teretoxins will have to come from characterization of mature venom peptides.
The seeming absence of PTMs in terebrid neuropeptides suggests that toxin sequences identified
at the genetic level can be directly synthesized and investigated for their therapeutic potential with more
confidence. However, their extended length is anticipated to pose challenges during SPPS synthesis, the
efficiency of which decreases with peptide length. Teretoxin synthesis by recombinant protein expression
is one strategy that can be used to address potential SPPS challenges.
2.5 Current approaches of conoidan toxin identification
Early experiments aimed at identifying neuropeptide components in snail venom relied on HPLC
48

venom fractionation , followed by Edman sequencing of peptide fractions exhibiting biological activity.
Subsequent investigations employed mass spectrometry (MS) instead of Edman degradation for
neuropeptide sequence elucidation, which had the advantages of requiring a substantially smaller sample
49

size and the ability to detect PTMs . The lower sample requirements allowed for the identification of a
larger number of venom components, but the throughput of whole venom fractionation was still limited
due to difficulties in obtaining enough crude venom for complete analysis.
Rapid advances in DNA sequencing technology have introduced a paradigm shift in snail venom
identification practices, which now focused on identifying potential neuropeptides by analyzing the snails’
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venom duct transcriptome. In a typical experiment, mRNA is extracted from the specimen’s venom duct,
and is subsequently used to construct a complimentary DNA (cDNA) library using in-vitro reverse
transcription followed by polymerase chain reaction (PCR) amplification. The amplified cDNA fragments
are then sequenced, and the resulting sequences are mined for defining features of disulfide-rich toxin
transcripts: the presence of a conserved signal sequence, and multiple cysteine codons in familiar
frameworks in the mature peptide region. The improved throughput of second generation sequencing
technology

50

allowed for analyses like these to be done at the genomic level, and further lowered the

sample size requirements and costs of transcriptomic analyses.
In addition to lower costs and sample size requirements, genetic identification strategies also
33

allow for targeted toxin discovery . Namely, information about signal sequences (and thus the gene
superfamily) as well as the cysteine residue arrangement (and thus the framework) allows for selecting
potential toxins that are inferred to be members of a particular pharmacological family. Alternatively,
transcripts with divergent signal sequences or rare or unknown cysteine frameworks can be selected in
hopes of identifying a novel biological target, or peptides with alternative interaction sites with traditional
targets. Coupling this genetic toxin identification strategy with cladistic analysis, as was done in our
51

laboratory for teretoxin identification, allows for a rational biodiversity guided discovery approach .
In spite of the advantages offered by neuropeptide identification by gene sequencing methods, it
has drawbacks when compared to direct venom fractionation. The obvious limitation is that information
available from genomic or transcriptomic analyses only provides the primary sequence of the target
peptide. The native configuration of disulfide bonds cannot be obtained from such an experiment.
Although it is sometimes possible to glean the probability of a certain PTM by the presence of a gene for
a corresponding enzyme, it is impossible to say with certainty that this PTM will be present in mature
peptide, or which specific residue(s) will be affected. Finally, predicting the cleavage site of the mature
toxin from an mRNA sequence can also be difficult. Thus, although genetic level toxin identification has
produced a number of advances, mass spectrometric interrogation of mature peptides from venom is still
very relevant, and is often used in combination with genomic/transcriptomic data in an integrated toxin
48

discovery strategy , which offers greater insights into toxin structure, PTMs, and the native folded state.
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Because of this continued relevance, modern advances in MS guided proteomics and de novo
sequencing methods continue to contribute to the field of snail neuropeptide discovery. For example, the
identification of teretoxin Tv1 from Terebra variagata (the synthesis, structural and functional
characterization of which is described as part of this dissertation), was accomplished by using just 4ng of
9

material extracted from the snail’s salivary gland by utilizing improved MS de novo sequencing methods .
Namely, the approach relies on using electron transfer dissociation (ETD) in addition to the ubiquitous
collision aided dissociation (CAD) for tandem MS (MS/MS) fragmentation, which greatly improves
sequence coverage. This method is specifically adapted to disulfide-rich toxins, because it relies on
derivatizing cysteine residues into dimethyl lysine analogues to achieve the higher charge states required
52

for ETD .
2.6 Current approaches to conoidan toxin synthesis
Peptide toxins have to be chemically synthesized to afford sufficient quantities for subsequent
structural and functional characterization. In the case of conotoxins, the preferred method is SPPS, as it
is highly efficient for short peptide sequences, amenable to automation, and offers the flexibility of
introducing PTMs where desired. Robust, standard SPPS protocols utilizing either tert-butoxycarbonyl
(Boc)

53

or 9-fluorenylmethoxycarbonyl (Fmoc)

54

for reversible α-amino protection exist. While Boc-SPPS

can be highly efficient at preventing on-bead peptide aggregation, it requires a specialized set-up for the
resin cleavage step, which uses gaseous hydrogen fluoride. In contrast, Fmoc chemistry does not require
highly specialized equipment, and although peptide aggregation can be a problem for certain sequences,
a number of techniques have been developed to mitigate these problems. The common issues
encountered in snail peptide SPPS are either associated with decreasing coupling and deprotection
efficiency with increasing peptide length, or with specific sequence-level features in a given peptide.
Some SPPS improvements to mitigate these issues include: engineering of solid supports with better
55

56

swelling properties in solvents of varying polarity , design of more efficient coupling agents ,
57

aggregation-disrupting pseudoproline backbone protection , dipeptide coupling to prevent aspartimide
58

5

formation , and microwave-assisted coupling . The synthetic utility of SPPS is further increased to longer
peptides and proteins when it is coupled with bioconjugation methods such as native chemical ligation
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(NCL) , a chemoselective joining of a peptide thioester with an N-terminal cysteine containing peptide
resulting in a native peptide bond.
Although longer peptide sequences of the Terebridae could be accessed with SPPS with the
aforementioned improvements, their presumed lack of PTMs also makes them amenable to biosynthesis
through recombinant expression. While cheaper than SPPS, recombinant expression is not usually used
for the synthesis of peptides, which tend to be unstable in common host organisms such as E. Coli. As a
workaround solution, peptides can be expressed as a fusion construct by appending their sequence onto
60

that of a protein that has good cytosolic solubility and high expression levels in the host . By engineering
a specific protease cleavage site between the neuropeptide and fusion protein partner coding regions, it
is possible to obtain the peptide of interest without any exogenous sequences.
After synthesis by either SPPS or recombinant expression, formation of disulfide bonds is
accomplished by a variety of oxidative folding protocols. While during SPPS peptides are always initially
formed in the linear (reduced) form, recombinant expression may produce a peptide with preformed
disulfides. While the latter case is unlikely in the common host E. coli because it has a reducing cytosol, it
is possible if a different host organism or specialized strain is used. Even if disulfides are formed during
recombinant expression, the peptide may still need to be subjected to reduction and refolding because
the disulfides formed in the host organism can be in a non-native arrangement.
Oxidative folding strategies for peptides containing multiple disulfides can be broadly classified
into two groups:

random oxidative folding of fully deprotected peptides, and directed regioselective
61

disulfide bond formation (Figure2.5) . During random folding, the fully deprotected peptide is dissolved in
a slightly alkaline buffer at high dilution (to prevent dimer and oligomer formation) and mild oxidizing
agents such as N,N-dimethylsulfoxide (DMSO) or thiol exchange reagents (such as a mixture of oxidized
and reduced glutathione) are added to facilitate disulfide bond formation. Polymer supported oxidizing
agents, such as ClearOx(cross-linked ethoxylate acrylate resin loaded with Ellman’s reagent) have also
62

been used for conotoxin folding , and provide the advantage of conducting folding reactions in reduced
volumes of buffer because of a pseudodilution effect. While cheap and easy to implement, random folding
is complicated by the number of disulfide bonds to be formed due to the number of possible isomers,
n

(2n)!/(2 n!) where n is the number of disulfides, that can arise during the process.
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Figure 2.5: One-step and regioselective folding strategies for disulfide-rich peptides
Although the presence of thiol exchange reagents attempts to mimic physiological folding
conditions allowing disulfides to reshuffle and direct the fold to the most thermodynamically stable
conformation, low yields can be observed due to formation of a number of kinetically trapped isomers
(Figure 2.6). Furthermore, the predominant isomer formed during random folding may not be the same as
the native form, since in the snails disulfides are formed during post-translational processing prior to
cleavage of the signal sequence and pre-pro regions, which aid in the recruitment of protein disulfide
61

isomerase (PDI) that in turn facilitates folding . Nevertheless, non-native disulfide-bond isomers may be
active analogues with interesting pharmacological properties, thus they can also be of interest. Random
folding experiments can be optimized by HPLC monitoring of reaction products while varying the reaction
temperature, time, peptide and thiol exchange reagent concentrations, as well as buffer salt content.
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A

B

Figure 2.6: Kinetically trapped intermediates in in-vitro folding reactions. A. HPLC trace and free
energy funnel representation of a folding reaction showing kinetically trapped intermediates. B. HPLC
trace and free energy funnel representation of a folding reaction with no kinetically trapped intermediates
Alternatively, if the disulfide arrangement of the toxin peptide is known, directed regioselective
folding could be employed to obtain only the desired isomer (Figure 2.5, right). In this approach, pairs of
cysteine residues that are known to form disulfides in the native toxin, are differentially protected during
SPPS. Following synthesis, the fully protected peptide is cleaved from the resin, and disulfides are
formed sequentially by selective deprotection of pairs of cysteines and subsequent stepwise oxidation.
Global deprotection takes place after all disulfides have been formed, and care must be taken to avoid
thiol reshuffling during this step. For peptides containing more than three disulfides, a semi-directed
approach can also be employed. Specifically, one disulfide is formed in a directed fashion, the peptide is
fully deprotected, and the remaining disulfides are formed by random oxidation. The conformational
restriction introduced by the pre-formed disulfide bridge directs the correct configuration of the remaining
disulfides. Alternatively, directed folding can be accomplished prior to cleavage of the peptide from the
solid support. This approach is attractive from a throughput standpoint because of its applicability to the
synthesis of combinatorial peptide libraries, but still faces a number of technical issues

38b

. Thus, although

some conotoxins were successfully made by on-resin oxidation, their folding yields in solution were
63

better . Finally, directed folding can also be achieved without the need for differential cysteine protection
64

by utilizing selenocysteine . Selenocysteine has a lower redox potential and a lower pKa than cysteine,
allowing for the diselenide bridge to be formed selectively, followed by disulfides. In context of the current
project, random folding is employed for the synthesis of teretoxins, because their native disulfide
configuration is unknown.
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2.7 Structural characterization of Conoidan toxins.
NMR spectroscopy has been the technique of choice for conotoxin characterization. While difficult
to crystallize, structural studies of these small and rigid peptides can often be accomplished by
homonuclear NMR without the need for isotopic labeling. However, NMR structural assignment still
requires a substantial amount of sample, and may be more difficult to implement for the larger toxins of
the Terebridae. Owing to the highly disulfide-bonded nature of these molecules, an alternative approach
relying on disulfide mapping followed by molecular dynamics (with explicit disulfide bridges) simulation
can be envisioned, and is developed in this work. Classic disulfide mapping in proteins is accomplished
by protease (usually trypsin) digestion, followed by mass spectrometric analyses of the peptide fragments
before and after complete reduction. Unfortunately, this is not very applicable to Conoidan peptides
because they lack sufficient protease sites and often contain adjacent cysteine residues. An alternative
disulfide mapping technique relies on partial reduction of disulfides followed by differential alkylation of
pairs of liberated cysteines. Edman sequencing of the fully reduced and differentially alkylated peptide
leads to disulfide assignment. In this work, the partial reduction and differential alkylation method is
utilized, but the analysis of the resulting differentially alkylated peptide is accomplished by tandem mass
spectrometry by adapting recently described methods

65

, which dramatically reduce sample requirements

and costs.
2.8 Current approaches to conoidan toxin functional characterization
Initial biological activity characterization of Conoidan toxins is traditionally accomplished by
66

means of phenotypic assays, such as by intracranial injection of a putative peptide toxin into mice , or
typical snail prey organisms such as Caenorhabditis elegans (C. elegans)

46a

. The phenotypic response

observed during this initial screening, is only indicative of general toxin function. Further attribution of
peptide toxin activity to a specific neuronal target is accomplished by means of electrophysiological
67

recordings utilizing voltage- or patch-clamp techniques . In this realm, ex-vivo tissue preparations with
extensively characterized ion channel and receptor distributions, such as mammalian dorsal root ganglion
68

(DRG) neurons , or HEK cell lines

69

have found numerous uses in the field of conotoxin research.

One extensively used method for electrophysiological characterization of Conoidan toxin
8

bioactivity relies on the use of oocytes of the African frog, Xenopus laevis as a model system . Devoid of
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endogenous ion channels, these large progenitor cells are engineered to express a specific ion channel
or receptor subtype by injecting them with genetic material (mRNA) coding for this specific target.
69

Heterologous expression of ion channels and receptors of interest in HEK cells have also been shown .
Subsequent electrophysiological recordings in the presence and absence of a putative peptide toxin, are
used to not only delineate the toxin’s specific neuronal target but also the mode of their interaction (i.e.
activation, deactivation etc).
While electrophysiological recordings provide functional information in excess of merely
identifying the specific ion channel being targeted, these methods suffer from low throughput. Efforts to
increase the throughput of these techniques include automated parallel electrophysiology platforms, the
70

use of fluorescent reporters sensitive to ion concentration, and ion flux assays . As an alternative,
binding assays utilizing radioactive or fluorescent tracers can be used to screen for biological activity of
conoidan peptides in a high-throughput manner, albeit without functional modality information.
2.9 Objectives of Thesis Project
The Holford laboratory focuses on adapting the techniques used in identification, synthesis,
structural and functional characterization of conotoxins to the neuropeptides of the Terebridae, a sister
group to the cones, to expand the existing pool of marine peptide natural products. While adapting
existing methods to these underexplored animals promises the discovery of peptides with novel neuronal
targets and modes of action, the methodology developed also attempts to address challenges of
throughput associated with disulfide-rich peptide discovery and characterization as a whole.
As a chemist in the lab, I was tasked with synthesis and structural characterization of terebrid
neuropeptides, as well as with chemical aspects of creating a high-throughput microarray based assay to
screen teretoxins against their biological targets. Specifically, the research objectives were:
1. Synthesis and oxidative folding of novel terebrid neuropeptides, utilizing modern SPPS and/or
recombinant synthesis strategies. Fmoc-SPPS procedures for manual and microwave-assisted synthesis
procedures were developed and implemented for the synthesis of teretoxins in Table 2.1. For the peptide
Tg77, a fusion-protein recombinant expression system was designed as part of this dissertation project,
and was subsequently implemented by Mary E. Wright, a biochemistry graduate student in our lab.
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Three of these peptides, Tg03, Tv1, and Arg58 were successfully assembled by Fmoc-SPPS. Random
oxidative folding optimization experiments on Tv1 and Arg58 were also carried out. The Fmoc-SPPS,
recombinant synthesis, and oxidative folding protocols that were adapted to teretoxins as part of this
dissertation project, are in continued use in the Holford laboratory.
Table 2.1: Teretoxin neuropeptides identified for synthesis

Peptide	
  
Tg55

Sequence

Tv1

TACEQHTDCSAASGPKYCCQDSDCCGGTEYICTNY
GQCLRSFGGRNDIFHLRLSRLTHRMKK (62AA)
SECETDDDCDIDQCCVEDTYFSSEWINVCSTCD
(33AA)
SLTEKAGGCPLYCSSQIFCCHGRKCRNVDGRLKCV
TEASMLGK (44AA)
TR(I/L)CCGCYWNGSKDVCSQSCC (21AA)

Arg58

PDICDGCPYKRGGDCCDLDIECC (23AA)

Tg03
Tg77

Identified From
T. guttata cDNA
T. guttata cDNA
T. guttata cDNA
T. variagata salivary
gland MS de novo
sequence
T. argyosia cDNA

2. Structural characterization of synthesized teretoxins by adapting a disulfide mapping technique based
on partial reduction, differential alkylation and tandem MS analysis. Optimization of differential alkylation
conditions and adaptation of ultra-high pressure liquid chromatography (UHPLC) methods resulted in the
successful disulfide mapping of Tv1, a teretoxin shown to induce a phenotypic response upon injection in
to polychaete worms. Analysis of MS/MS data, which contributed to the assignment, was done in
collaboration with Dr. Vadi Bhatt from Agilent technologies.
.
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Chapter 3: Synthesis, Oxidative Folding of Terebrid Neuropeptides and Structural
Characterization of a Novel Venom Peptide Tv1 From the Venomous Marine Snail
Terebra variaga
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3.1 Teretoxins: from identification to synthesis and characterization
Conoidan peptides are attractive targets for pharmaceutical and neuroscience research
applications. In a quest for identifying compounds with novel biological targets, as well as to enrich the
peptide marine natural product pipeline in general, the Holford laboratory is focused on the study of the
venom peptides of the Terebridae, a sister group to the cones, whose toxins are much more well known.
This laboratory has been exceedingly successful in identifying putative peptide toxins from terebrid
species, in part through implementing a biodiversity-guided rational discovery method, dubbed the
71

“concerted discovery strategy” (Figure3.1) . Instead of randomly selecting specimens for mining peptide
toxin sequences, the strategy relies on the use of taxonomic tools for phylogenetic analysis, which in turn
allows identification of potential toxins from divergent lineages, thus maximizing diversity of lead peptides.
Correlating phylogenetic information with the anatomy of the Terebridae allowed for identification of
several lineages that have lost their venom apparatus, and thus helped refocus toxin discovery efforts
only on the clades that retained this anatomical feature. The application of this strategy has resulted in
myriad cDNA transcripts of putative toxins identified from terebrid species, several of which were selected
for further investigation. Through work with collaborators, who focus on improving de novo mass
52

spectrometric sequencing methods of disulfide-rich peptide toxins , terebrid toxins were also identified
from crude venom.
While identification of putative toxins is an important step in the development process, chemical
synthesis is required for sufficient quantities of the peptide toxins to be available for functional assays.
Additionally, structural characterization of biologically active terebrid neuropeptides is needed to delineate
the structure-activity relationships with their targets. This part of the dissertation project focuses on
chemical synthesis of putative toxins of the Terebridae identified by the Holford lab and collaborators, as
well as their structural characterization. Numerous studies of disulfide-rich venom peptides of cone snails,
serve as a general guide for the workflow of synthesis, oxidative folding and structural characterization of
terebrid peptides. While adapting these existing techniques to teretoxins is itself a challenge,
improvements in throughput during these stages of the toxin development process are also needed. This
bottleneck in throughput in the synthesis and characterization stages is particularly evident in examining
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ConoServer data, with 2837 toxin sequences identified and only 175 characterized (ConoServer
37

accessed on 5/16/15) .

Figure 3.1:Traditional and concerted discovery strategies for teretoxins. A. Traditional strategy.
Analyzed species are chosen randomly, and may correspond to a single lineage. Prospective toxin
analysis starts first with characterization of venom components by HPLC (venom fractionation). B.
Concerted Discovery Strategy (CDS). Taxonomic tools are used first to identify independent lineages to
maximize the species, and thus teretoxin diversity, and then to analyze the numerous cDNA compounds
isolated from each analyzed specimen. Application of CDS increases discovery of divergent teretoxins.
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SPPS is the conotoxin synthesis strategy of choice, particularly efficient for their short sequences,
and amenable to installation of a variety of PTMs encountered in these peptides. The longer peptide
toxins of the Terebridae push the limits of this strategy, necessitating special improvements to the
process. The apparent lack of PTMs in teretoxins, however, makes it possible to synthesize these toxins
recombinantly. SPPS protocols adapted to sequence features and lengths of specific teretoxins are
developed in this work. Particularly, microwave-assisted automated synthesis is used to combat
inefficiency of SPPS of longer peptides, as well as to improve throughput. A recombinant expression
strategy for the cost-effective synthesis of longer teretoxins is also designed as part of this project.
Correct formation of intramolecular disulfides in conoidan toxins is key to their activity. Decades
of conotoxin research identify a number of oxidative folding protocols, both random and regioselective, for
this purpose. Due to the nature of techniques used to identify teretoxin sequences in our laboratory, there
is no information about their native disulfide connectivity. Therefore, random oxidative folding procedures
are used for the teretoxins synthesized for this thesis work. A variety of folding conditions are evaluated to
maximize the yield of the desired bioactive isomer.
NMR is traditionally used for structural characterization of conotoxins. Their small size and highly
disulfide-bonded rigid structure make NMR structural assignment of conotoxins possible often even
without isotopic labeling. However, NMR analyses still have high sample requirements, and the larger
peptides of the Terebridae may necessitate costly isotopic enrichment for unambiguous structure
determination. Instead, this work focuses on developing a mass spectrometric approach for the disulfide
mapping of teretoxins, as means of their structural characterization.
Traditionally, HPLC is used throughout synthesis, oxidative folding, and disulfide mapping of
peptide toxins, to ascertain SPPS yields and side products, monitor progress of folding reactions, and
separate partially reduced peptide species. In this work, the newly developed ultra high-pressure liquid
72

chromatography (UHPLC) , is adapted for these purposes. This technique offers greatly shortened
analysis time, as well as reduced solvent requirements relative to traditional HPLC. Adapting UHPLC for
the development of teretoxins demonstrates another way to improve the throughput of synthesis and
characterization stages of peptidic marine natural product development.
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3.2 Results and Discussion
Terebrid neuropeptide sequences selected for development are listed in Table 3.1, along with
methods chosen for their synthesis, and successfully completed development stages. Fmoc SPPS was
chosen for production of peptides Tg55, Tg03, Tv1 and Arg58.

Table 3.1: Teretoxin neuropeptides identified for development
Peptide
Tg55
T. guttata
cDNA

Tg03

Sequence

Synthesis Folding Activity Structure

TACEQ5HTDCS10AASGP15KYCCQ20DSDCC25GGTEY30ICTNY35GQCLR40SFGGR45NDIFH50LRLSR55LTHRM60KK62

T. guttata
cDNA

SECET5DDDCD10IDQCC15VEDTY20FSSEW25INVCS30TCD33

Tg77

SLTEK5AGGCP10LYCSS15QIFCC20HGRKC25RNVDG30RLKCV35TEASM40LGK43

T. guttata
cDNA

Arg58
T. argyosia
cDNA

N/A

PDICD5GCPYK10RGGDC15CDLDI20ECC23

Tv1
T. variagata TR(I/L)CC5GCYWN10GSKDV15CSQSC20C21
MS de-novo
sequence
For peptides made by SPPS, double-coupled residues are in bold. Tg55 sequence highlighted in red was to be assembled as a peptide
thioester for subsequent NCL.Underlined sequence DG was introduced as a dipeptide.

In straight chain synthesis, peptides are assembled from the carboxy (C) to amino (N) terminus,
by successive couplings of activated esters of Nα-Fmoc protected amino acids onto a solid support
(Figure 3.2). Fmoc amino acids are routinely activated by O-Benzotriazole-N,N,N’,N’-tetramethyluronium
hexafluorophosphate (HBTU) in the presence of diisopropylethylamine (DIPEA) for coupling, and
deprotected with 20% piperidine in DMF. Reactive side chain functionalities of the Fmoc amino acid
building blocks are protected with standard acid-labile groups. When the target sequence is reached, the
peptide is fully deprotected and cleaved from resin by a cocktail of trifluoroacetic acid (TFA) and
scavengers. Manual SPPS was initially used in attempts to synthesize Tg55, Tg03, as well as to establish
general protocols for syntheses of terebrid neuropeptides. Using the manual SPPS methods as a guide,
syntheses of Tv1 and Arg58 were completed by an automated microwave peptide synthesizer. During
manual synthesis, the ninhydrin test for free amines is used to assess the efficiencies of coupling and
deprotection reactions, while in automated synthesis, the waste stream from the deprotection reaction is
analyzed spectrophotometrically for the UV-absorbing Fmoc group.
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Figure 3.2: Straight chain Fmoc SPPS diagram
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Information from these assessments is then used for synthesis optimization by using a longer coupling
time, more effective coupling reagent, or double-coupling (repeating a coupling reaction) a specific amino
acid.
Attempts at synthesizing Tg55 by manual Fmoc SPPS were severely hampered by decreasing
coupling efficiency with increasing peptide length. However, its C-terminal fragment Tg55(31-62), bearing
an N-terminal cysteine was successfully assembled, suggesting a possible strategy of assembling Tg55
from two SPPS prepared halves joined through NCL (Figure 3.3).
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Figure 3.3: Tg55 convergent synthesis by SPPS and NCL
In this approach, a peptide thioster fragment is joined to another fragment containing an N-terminal
cysteine residue to yield a native peptide bond through an S to N acyl shift. The thioester fragment,
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73

Tg55(1-30), was to be assembled on a sulfamylbutyryl “safety catch” resin , which allows the generation
of peptide thioesters on the solid phase, via activation of the linker with trimethylsilyldiazomethane
(TMS-CH2N2) after standard SPPS, and cleavage of the peptide by nucleophilic displacement with a thiol.
Both fully deprotected Tg55 fragments are then joined by NCL in the presence of thiols under mildly
denaturing aqueous conditions. However, repeated attempts to generate the peptide thioester Tg55(1-30)
were unsuccessful, due to inefficiency of loading the slufamylbutyryl “safety catch” resin. The difficulty of
74

loading this resin, as well as cleavage of thioesters from it is well documented , and despite using the
chaotropic salt LiBr, which was proven to enhance resin swelling and aid in loading reactions onto the
75

sylfamylbutyryl linker , no thioester cleavage products were observed during repeated test cleavages of
Tg55 peptide fragments from this resin. Due to these difficulties, its synthesis was not pursued further.
Manual synthesis of the peptide Tg03 successfully resulted in a product corresponding to the
calculated mass of the peptide. However, this peptide’s extremely low isoelectric point, resultant from 11
acidic residues within its sequence, made it difficult to handle, particularly during HPLC purification.
Because of general problems of solubility of this peptide, and its incompatibility with HPLC buffers, its
oxidative folding and structural characterization was not pursued.
Both Tv1 and Arg58 were successfully synthesized by automated microwave-assisted Fmoc
SPPS. Due to inherent uncertainty in the MS derived de novo sequence, both Leu3 and Ile3 homologs of
Tv1 were assembled for subsequent oxidative folding and structural characterization.
A recombinant synthesis strategy, including choice of vector, solubilizing protein fusion tag, host
organism allowing for disulfide bond formation, and protease cleavage site to afford the native peptide
without exogenous sequences was designed (Figure 3.4). In addition to being optimized for efficient
76

production of disulfide-rich peptides, this strategy also uses ligation-independent cloning (LIC) , a time
and cost saving measure. LIC eliminates the need of treating an expression vector and insert with
restriction endonucleases, dephosphorylating the vector, using DNA ligase, and all of the associated DNA
purification steps. Instead, LIC uses the proofreading function of DNA polymerase to create long (1012bp) complimentary overhangs during PCR in the absence of a single deoxyribonucleotide phosphate.
The insert is simply added to the linearized vector with complimentary 10-12bp overhangs, and this
mixture is used directly to transform competent host cells, without the need for DNA ligation.
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The

implementation of this recombinant synthesis strategy by a biochemistry graduate student, Mary E.
77

Wright, resulted in successful synthesis of Tg77 .

As teretoxins contain multiple cysteine residues, their oxidative folding into the biologically active
conformation may at times be challenging. Synthetic peptide toxins are folded in solution by employing
various oxidizing agents. However, because there are multiple arrangements of disulfide bonds, the
formation of biologically inactive, kinetically trapped folding intermediates is possible. To avoid this, many
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folding reaction conditions must be evaluated. In the folding of Tv1 and Arg58, dimethylsulfoxide (DMSO),
mixtures of oxidized and reduced glutathione (GSH:GSSG), and ClearOX (immobilized Ellman’s reagent)
were all evaluated as oxidizing agents. The best results were obtained with GSH:GSSG mixtures, and the
folding yields of Tv1 were further optimized for maximal yield of the active folded product by varying the
reaction time, temperature, pH, and salt concentration. Arg58 folding was not optimized further because
no functional activity was confirmed for any of its folded products. Functional testing of Arg58 is ongoing
in the Holford laboratory.
Following confirmation of its biological activity in a phenotypic assay in polychaete worms,
disulfide mapping of Tv1 was accomplished by a strategy of partial reduction and differential alkylation
coupled with MS/MS analyses (Figure 3.5). A similar strategy, utilizing UHPLC and nanoflow LC-MS was
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successfully used for disulfide mapping using just picomols of sample . This method is well suited for
teretoxins as many of them have an inadequate number of protease cleavage sights, barring the
traditional protease digest and MS approach. In this strategy the folded neuropeptide is first partially
reduced at low pH using TCEP. The partially reduced species are then separated by RP-HPLC, and
immediately alkylated with n-ethylmaleimide (NEM) at low pH. Excess NEM is removed by desalting.
Keeping the pH low during these steps is crucial in preventing disulfide scrambling. The remaining
disulfides of each partially reduced conformation are then reduced completely and either alkylated with
Iodoacetamide (IAM) or left as free sulfhydrils. Following a final desalting, the partially reduced and
differentially alkylated species are subjected to MS/MS. Upon entering the collision chamber of the mass
spectrometer, the peptides break along the backbone producing characteristic N-terminal b, and Cterminal y ions. Analysis of b and y ions of each partially reduced and alkylated species, yields
information on one disulfide bond connectivity. Thus, for the disulfide mapping of a peptide containing
three disulfide bonds, it is necessary to analyze at least two non-redundant partially reduced and
alkylated species to assign the framework. All six possible partially reduced Tv1 species were
successfully resolved, differentially alkylated, and provided non-conflicting information on its disulfide
1

connectivity. This disulfide assignment was further confirmed by solution H NMR of Tv1.
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Figure 3.5: Partial reduction, differential alkylation, and MS/MS analysis for disulfide mapping of
teretoxins. For simplicity, the scheme is shown on a peptide with two disulfides
3.2.1 Synthesis of selected terebrid neuropeptides
Manual solid phase peptide synthesis of Tg55 proceed relatively smoothly through Phe42,
although bulky amino acids had to be double-coupled (double-coupled residues are shown in bold in
Table 3.1). After Phe42, decreased coupling and deprotection efficiency, as ascertained by the ninhydrin
test, necessitated double-coupling of every subsequent residue, and capping unreacted resin bound
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deletion products with acetic anhydride. Despite considerable efforts, deletion products and truncated
peptides dominate the HPLC spectrum of Tg55(32-62), with a marked increase in these unwanted
species observed relative to the fragment Tg55(47-62) (Figure 3.6). Although the presence of Tg55(3262) among the many cleavage products was confirmed by MS, its purification was not immediately
attempted because easier separation was envisioned after NCL with Tg55(1-31) thioester. Unfortunately,
repeated attempts to synthesize the Tg55(1-31) thioester fragment were unsuccessful, and SPPS
synthesis of Tg55 was not pursued further.
Tg03 was successfully assembled by manual SPPS, as confirmed by mass spectrometry (Data
not shown). However, its low isoelectric point conferred very low solubility in acidic HPLC buffers.
Attempts to use basic HPLC buffers were complicated by decreased column performance at high pH.
Due to these solubility and handling problems, the development of Tg03 was not pursued further.

A

B

Figure 3.6: HPLC monitoring of SPPS cleavage products of Tg55. A.Cleavage of Tg55(47-62), a
26mer, peak at 20.015min corresponds to desired peptide. B. Cleavage of Tg55(32-62), a 31mer, peak at
21.520min corresponds to desired peptide.
Arg58 was successfully synthesized by automated microwave-assisted SPPS. Previous attempts
at manual synthesis of this peptide have identified sequence regions that suffer from low coupling
efficiency. Utilizing this information, selected residues were programmed to be double-coupled during
automated SPPS. To further minimize unwanted side products, the aspartimide formation prone
sequence Asp-Gly (underlined in Table 3.1) was introduced as a backbone dimethoxybenzyl (dmb)
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protected dipeptide and double-coupled. Figure 3.7 shows the UHPLC traces of purified Arg58, and its
mass spectrum.

A

B

Figure 3.7: UHPLC and MS of synthesized Arg58. A. UHPLC trace showing the desired peptide
denoted with an asterisk. B. MALDI-TOF spectrum of synthesized Arg58 showing [M+H] 2494.46,
calculated mass is 2493.85
Both Leu3 and Ile3 variants of Tv1 were successfully assembled by automated microwaveassisted SPPS. Double coupling of the first three residues was used to improve synthetic efficiency, using
information from prior synthesis attempts. The HPLC and MS of Tv1 are shown in Figure 3.8.
Furthermore, the MS/MS spectrum of synthetic Tv1 is practically identical to that of native Tv1 (Figure
3.9), confirming the validity of its de novo sequence assignment. Both Leu3 and Ile3 were used in
subsequent folding, functional and structural experiments, but behaved nearly identically. For
convenience, only Tv1(Ile3) data is shown in subsequent sections.

	
  

39	
  

	
  

A

B

Figure 3.8: UHPLC and MS of synthesized Tv1: A . UHPLC trace of purified syntheticTv1. B. MALDI-TOF spectrum of synthesized Tv1 showing [M+H] 2316.32, calculated mass is 2316.87
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Figure 3.9: ETD spectra of native (black) and synthetic Tv1 (blue). MS/MS spectrum recorded on a
(M + 6H)+6 ion after conversion of cysteine residues to dimethyl lysine analogs. The sequence is given
above the spectrum and observed c and z-type fragment ions are indicated in the sequence. The spectrum was recorded at a resolution of 7500 at m/z 400 and all fragment ions have a mass accuracy of
better than 5 ppm.
The peptide Tg77 was successfully produced recombinantly, following a strategy developed as
part of this dissertation project. Figure 3.10 shows the production of Tg77-GST fusion protein during
expression in E. coli Origami B, and Figure 3.11 shows the cleavage of mature Tg77 by enterokinase.
After optimization of enterokinase cleavage conditions, a yield of 2.5mg Tg77/L of culture was obtained.
MS analysis of recombinant Tg77 shows that the peptide has been produced in a folded state, consistent
with a reduction of mass associated with a loss of 6 protons during the formation of 3 disulfides.
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Figure 3.10: SDS-PAGE analysis of expression and purification of Tg77 fusion protein. M - protein
molecular weight marker. Lane 1 - Tg77 crude lysate. Lane 2 - Tg77 crude lysate after binding to
nickel-NTA resin. Lanes 3,4 - washing steps. Lane 5 - purified Tg77 fusion protein. Figure reproduced
from reference 77

A.

B.

Figure 3.11: HPLC monitoring of enterokinase cleavage and LC-MS of recombinantly produced
Tg77. A. Semi-preparative HPLC of folded Tg77. B. LC-MS characterization of folded Tg77 (expected
mass: 4756.2 Da, Observed: 4756.2 Da). +4, +5, +6, +7 charge states are shown. Figure reproduced
from reference 77
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3.2.2 Oxidative folding of terebrid neuropeptides Tv1 and Arg58
Both Tv1 and Arg58 were folded using 10:1 GSH:GSSG as the oxidizing agent. UHPLC
monitoring of folding reactions allowed for rapid screening of a variety of folding conditions. UHPLC
monitoring of Tv1 over time, shows production of predominantly a single isomer within 2 hours (Figure
3.12). The effect of temperature, pH, and salt concentration on folding yields of this isomer of Tv1,
measured as %area of this peak (UV detection of HPLC folded products at 229nm), were investigated
(Figure 3.13). The optimal conditions for Tv1 folding were after incubation for 4 hours at 4°C (20µM Tv1,
1.0M NaCl, 0.1M Tris, 0.1mM ethylenediaminetetraacetic acid (EDTA), 10mM GSH, 1mM GSSG), with
over 90% yield of the desired isomer. Figure 3.14 shows the UHPLC trace, and MS confirmation of the
biologically active folding product of Tv1 purified to 99%.

Figure 3.12: UHPLC monitoring of oxidative folding of Tv1 over time. 20μM Tv1 in 0.1M Tris pH 7.4,
0.1mM EDTA, 1M NaCl, 10mM GSH and 1mM GSSG. UHPLC UV detection at 229nm.
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Figure 3.13: Optimization of oxidative folding of Tv1. Y-axis represents the yield of biologically active
folding product of Tv1 as ascertained by UHPLC with UV detection at 229nm. 20�M Tv1, 0.1M Tris,
0.1mM EDTA, 10mM GSH and 1mM GSSG. +salt indicates addition of 1M NaCl.
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A.

B.

Figure 3.14: UHPLC and MALDI-TOF analysis of purified folded Tv1. A. UHPLC trace of folded Tv1
purified to 99%. B. MALDI-TOF spectrum of forlded Tv1 showing [M+H] 2310.74 Da, expected [M+H]
2310.82
Arg 58 folding resulted in approximately 60% yield of one isomer (Figure 3.15). Biological activity
testing of this isomer, as well as four other isolated minor folding products of Arg58 did not indicate
activity, presumably due to limitations of the assays employed. Additional functional testing of folding
products of Arg58 using alternative methodologies is ongoing, and further folding optimization and
structural characterization of this peptide is reserved until confirmation of biological activity.
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A.

B.

Figure 3.15: UHPLC and MALDI-TOF analysis of folded Arg58. A. UHPLC trace of Arg58 folding
products. Major product is denoted with an asterisk . B. MALDI-TOF spectrum of Arg58 major folding
product showing [M+H] 2489.54 Da, expected [M+H] 2487.80 Da
3.2.3 Structural characterization of Tv1: disulfide mapping by partial reduction, differential alkylation and
MS/MS analysis
The major folding product of Tv1 obtained using optimized conditions, isolated and purified to 98% using
semi-preparative HPLC, was subjected to partial reduction by tris-carboxyethylphosphine (TCEP) in
citrate buffer pH 3.0. The reaction time and TCEP concentration was evaluated by direct injection of
reaction contents onto UHPLC column, and analyzing partially reduced products. All six possible partially
reduced species were observed upon optimization of reaction conditions (Figure 3.16). The UHPLC
method was then transferred to an HPLC platform to allow for manual collection of partially reduced Tv1
products. Upon HPLC separation, the six partially reduced species were collected directly into tubes
containing an NEM alkylating solution (pH 3.0). Following alkylation, excess NEM reagent was removed
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by a UHPLC desalting protocol. The desalted, NEM alkylated species were then reduced completely by
incubation with 100mM TCEP, and alkylated with IAM. The resulting species, labeled with two, four, or six
NEM and/or IAM groups were once again desalted using UHPLC, lyophilized, and subjected to LCMS/MS to determine NEM and IAM alkylation sites by matching the MS/MS data to b- and y- series ions
to theoretical patterns. These analyses of all six differentially alkylated species provided complimentary
and non-contradictory information, resulting in the connectivity assignment: Cys4-Cys20, Cys5-Cys21,
and Cys7-Cys16 (Table 3.2).
Table 3.2. Predicted and observed of b and y ions of differentially alkylated peptides by auto and
targeted MS/MS analysis
Sequence

Ions

Unmodified	
  
peptide	
  
(m/z)

m/z	
  
(thr.)

m/z	
  
(obs.)

Difference

Modifications

MS/MS	
  for	
  precursor	
  ion-‐m/z	
  932.026	
  (+3)	
  of	
  parent	
  ion	
  2793.0552	
  
TRIC

b4

474.2493	
  

599.2902

599.297

125.0414

NEM

TRICC

b5

577.2585	
  

759.3197

759.3276

125.0414+57.0198

NEM+IAM

C

y1

122.0270

179.048

179.0485

57.021

IAM

CC

y2

225.0362

407.1048

407.1054

57.021+125.0476

IAM+NEM

CCSQSC

y6

630.1680

869.2579

869.2586

57.021+125.0476+125.0479

IAM+2NEM

MS/MS	
  for	
  precursor	
  ion-‐m/z	
  977.376	
  (+3)	
  of	
  parent	
  ion	
  2929.1027	
  
TRICCG

b6

634.2800

884.3632

884.3753

250.0832

2NEM

TRICCGC

b7

737.2891

1044.4083

1044.406

307.1192(250.0831+57.036)

2NEM+IAM

C

y1

122.0270

247.0747

247.0747

125.0477

NEM

CC

y2

225.0362

475.1292

475.1316

250.093

2NEM

CCSQSC

y6

630.1680

937.2707

937.2849

57.0188+250.0859

IAM+2NEM
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Figure 3.16: UHPLC analysis of partially reduced Tv1 peptide on a UPLC (BEH 300 C18 1.7µm,
Waters Corporation, Milford, MA, USA) column, a linear gradient of 0-75% buffer B (80% acetonitrile,
0.1% TFA) in buffer A (0.1% TFA) over 6 minutes and peaks were assigned by their degree of reduction.
Labels indicate how many disulfides are present.
	
  
This connectivity was also confirmed by an NMR solution structure of Tv1, obtained by collaborators
Mohammed Bhuiyan and Sébastien Poget (Figure 3.17). Despite having a cysteine scaffold similar to
M-superfamily conotoxins, the disulfide connectivity of Tv1 has not been previously observed in Conus
79

Peptides .
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A.

B.

Figure 3.17: NMR confirmation of Tv1 disulfide assignment. A. NOE contacts confirming the C7-C16
disulfide bond. An overlay of the HNHα fingerprint region of the NOESY (in black) and TOCSY (in blue)
spectra shows NOE crosspeaks linking Cys 16 and Cys 7 as well as contacts in the residues flanking the
C7-C16 disulfide bond (C7-S17, Y8-C16, G6-C16, G6-N18). B. An overlay of a cartoon representation
and a stick model of the lowest-energy structure of Tv1 shows the β-sheet character of the peptide and
reveals the important role of the Tyr 8 side chain in the formation of a small hydrophobic core. Figure
reproduced from from reference 9.
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3.3 Conclusions and future directions
Adapting techniques from conotoxin research and coupling them with modern techniques to
increase throughput successfully established the synthesis and structural characterization capabilities of
the Holford laboratory. Difficulties during early manual synthesis attempts of terebrid peptides lead to the
development of improved protocols. Automated microwave-assisted peptide synthesis allowed for faster
assembly of peptides, and gave access to SPPS of longer teretoxins. Use of UHPLC for analyzing SPPS
cleavage products, analytical confirmation of peptide purity, and monitoring oxidative folding reactions
dramatically reduced the time and cost of peptide synthesis, and oxidative folding. This success is
demonstrated with the synthesis and structural characterization of Tv1, the first terebrid peptide toxin to
9

be structurally characterized . Demonstrated to be active in a phenotypic assay in polychaete worms, the
cysteine connectivity of Tv1 is unlike that of similar M-superfamily conotoxins (figure 3.18), suggesting
that it may have a novel biological target or mode of action. Efforts to identify its biological target using
electrophysiological recordings, and cell-based assays are ongoing.

Figure 3.18: Structural comparison of Tv1 teretoxin and M-superfamily conotoxins.
Comparison of the NMR structure of Tv1 with that of M superfamily conotoxins SmIIIA, mr3e, and KIIIA
reveals significant structural differences between Tv1 and these conotoxins despite all having the same
cysteine scaffold CC-C-C-CC. All structures are shown in cartoon representation with disulfide bonds
highlighted in yellow. All figures were prepared using PyMol (www.pymol.org). Conotoxin structural
references are as follows: MrIIIe79d SmIIIA79g and KIIIA79h.
The recombinant expression strategy developed for Tg77, was also proven effective, particularly
for longer teretoxins. Besides being a viable route for teretoxin synthesis, it also incorporates an
improvement in throughput by using ligation independent cloning. A recombinant expression system
analogous to that designed for Tg77, was also used to successfully produce two more toxin peptides from
77

Cingulaterebra Anilis Can1, by graduate student Mary E. Wright , illustrating the general applicability of
this method to the synthesis of teretoxins.
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3.4 Materials and methods
3.4.1 SPPS of terebrid neuropeptides
All peptide acids were synthesized on Wang-Cl resin. This resin was prepared from commercially
available Wang resin (Anaspec) using a previously published procedure

80

. Racemization free loading of

80

the first amino acid was also completed as previously described . After conjugation of the first (Cterminal)

Nα-Fmoc-amino

acid

(Fmoc-AA-OH),

resin

substitution

was

calculated

using

a

spectrophotometric Fmoc release assay. Briefly, 10-20mg resin aliquots were weighed out, and
deprotected with 1mL of 20% piperidine in (DMF) for 1 hour. An aliquot of the deprotection solution was
then diluted 100 fold, and its 1mm absorbance at 301nm was used to calculate resin loading according to:
𝑆(𝑚𝑚𝑜𝑙𝐴𝐴/𝑔  𝑟𝑒𝑠𝑖𝑛) =

101×𝐴!"#
  
7.4×(𝑚𝑔  𝑟𝑒𝑠𝑖𝑛)

During Fmoc-SPPS, standard side chain protecting groups were used for all amino acids. Due to
absence of a priori knowledge of disulfide connectivity, the trityl protecting group was used for all cysteine
side chains. Chain elongation steps, namely coupling Fmoc-AA-OH, and removal of the Fmoc protecting
group differed for manual and automated microwave-assisted synthesis. During manual synthesis,
coupling was effected by adding 3eq. of the Fmoc-AA-OH, 2.99eq. HBTU, and 6eq DIPEA, all dissolved
in a minimum amount of DMF, and incubating for 1 hour with stirring. Up to 50% dichloromethane was
added to improve resin swelling properties during difficult coupling reactions. If repeated couplings failed
to completely react, resin-bound peptides were capped with 10eq Acetic anhydride and 11eq DIPEA in
DMF to produce Nα-Acetyl capped products in lieu of deletion products which are harder to separate from
the desired peptide upon cleavage. Deprotection was effected by exposing the peptidyl resin to 5
volumes of 20% piperidine in DMF for 5 minutes, then 30 minutes. DMF solutions containing 2% 1,8Diazabicyclo[5.4.0]undec-7-ene (DBU) and 18% piperidine were used as alternatives for difficult
deprotection reactions.
The ninhydrin test for free amines was used to evaluate the efficiency of coupling and
deprotection reactions. Briefly, a small aliquot of peptidyl resin (10-30 single resin beads) was withdrawn
from a peptide synthesis vessel, washed, dried under vacuum, and transferred to a 100mm culture tube.
One drop each of reagent A (5% w/v ninhydrin in ethanol), B (4:1 phenol:ethanol), and C (2% v/v of 1mM
aqueous KCN in pyridine) were added to the resin, and the tube was heated to 110°C for 3 minutes. Blue
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coloration of resin beads indicates the presence of free amines. Couplings reactions were considered
complete when resin beads remained colorless after this procedure.
Microwave-assisted, automated peptide synthesis was completed on a Liberty1 instrument (CEM
corporation). Coupling reactions used 5eq. Fmoc-AA-OH(as 0.5M solution in DMF), 4.99eq. HBTU and
10eq. of DIPEA (in N-methyl-2-pyrrolidone), and proceeded for 5min, under up to 25W microwave power,
while maintaining a reaction vessel temperature of no greater than 75°C. Coupling of Fmoc-Cys(trt)-OH
and Fmoc-His(trt)-OH, was restricted to no greater than 50°C, to prevent racemization and thermal
cleavage of the trityl group. Fmoc deprotection was effected by 20% piperidine in DMF containing 0.1M 1hydroxybenzotriazole (HOBt), for 1 min, then 4 min, at 25W maximum power and 75°C maximum
temperature. Residues were preprogrammed to be double-coupled based on information from previous
manual synthesis attempts, as well as in peptide regions containing several bulky aliphatic amino acids in
succession. During the synthesis of Arg58, the aspartimide prone sequence Asp-Gly, was introduced as a
dmb-protected dipeptide, Fmoc-Asp(OtBu)-(Dmb)Gly-OH (Novabiochem), and double coupled.
Cleavage of peptides from the resin, and removal of all side chain protecting groups was
accomplished by shaking the peptidyl resin with 5 volume equivalents of reagent K (92.5% trifluoroacetic
acid (TFA), 2.5% triisopopylsilane (TIS), 2.5% 1,2-ethanedithiol (EDT) and 2.5% water) for 4 hrs. Reagent
K supernatant containing cleaved products was then filtered from the resin, and peptide components
were precipitated by addition of 50 volume eq. of cold methyl-tert-butyl-ether.
Peptide cleavage products were then dissolved in HPLC buffer A (0.1% TFA), and assayed using
a generic reversed phase UHPLC elution protocol. Briefly peptide cleavage products were loaded onto an
Acquity UPLC BEH300 C18 column (4.6x50mm, 1.7um particle size, Waters corporation, MA), and
elution was carried out at 0.6mL/min with 97% HPLC buffer A and 3% HPLC buffer B (80% acetonitrile
(ACN), 0.1% TFA) for the first 20 seconds, then increasing HPLC buffer B to 75% in a linear gradient over
2 minutes. This initial screen was used for gradient optimization for each peptide synthesized. Once
maximal resolution of peptide product from truncated and deletion sequences was attained, the UHPLC
method was scaled to semi-preparative HPLC, taking into account column dimensions and particle size to
calculate appropriate flow rates and duration of gradient steps. Semi-preparative purification of
synthesized Tv1 was completed on an X-Bridge column (10x150mm, 5um particle size, Waters
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Corporation, MA) by elution at 5mL/min of 20% HPLC buffer B and 80% HPLC buffer A for the first 5
minutes, then increasing HPLC buffer B to 35% in a linear gradient over 45min.
The identity of synthesized peptides was confirmed by molecular mass measurement using a MALDITOF (Waters Micromas, MA) instrument, and α-Cyano-4-hydroxycinnamic acid (CHαCN) as matrix.
3.4.2 Oxidative Folding of Teretoxin peptides
Early experiments on several teretoxin peptides tested dimethylsufloxide (DMSO) and ClearOX
resin as potential oxidizing agents in folding reactions. The yields of these reactions were substantially
lower than with mixtures of oxidized and reduced glutathione (data not shown). For routine teretoxin
folding, the starting reaction conditions are 20µM of linear purified peptide incubated in 0.1M Tris-HCl pH
7.5, 0.1mM EDTA, 10mM GSH and 1mM GSSG. Aliquots of this initial folding reaction are then stopped
after 15 min, 30 min, 1, 2, 3, 4, and 24 hours by acidification with formic acid (to 8% v/v), and the products
analyzed by UHPLC using the same column and buffers as described earlier, but with an optimized
gradient for each peptide. Further folding optimization is accomplished by varying the reaction
temperature, pH, and including up to 1M NaCl in the folding reaction. For Tv1, optimized folding
conditions were: 20uM Tv1 incubated in 0.1M Tris pH 10, 1M NaCl, 0.1mM EDTA, 10mM GSH and 1mM
GSSG for 4 hours. The identity of oxidized teretoxins is confirmed by MALDI-TOF. For Tv1, the optimized
folding reaction was scaled up, and the product purified on an X-Bridge semi-preparative column (See
above) by eluting at 5mL/min with 15% buffer B and 85% buffer A for the first 5 min, then increasing
buffer B to 35% in a linear gradient over 45 min.
3.4.3 Disulfide mapping of Tv1
Purified folded Tv1 was subjected to partial reduction and alkylation procedure by modifying
previous protocols

78, 81

. Briefly, 9µL of 1mM Tv1 dissolved in 0.1M citrate pH 3.0 was mixed with 1µL

20mM TCEP, and incubated in an HPLC microvial for 90min at 4°C. Reduction was stopped by direct
injection onto an RP-HPLC X-bride column (4.6x150, 5um particle size, Waters Corporation, MA) and
eluted with 20% buffer B in buffer A for 5 min, then increasing buffer B to 35% in a linear gradient over 75
min. Six partially reduced species (Figure 3.16) were then collected directly into tubes containing 100uL
of 200mM NEM in citrate pH 3.0, and incubated for 2h at 37°C. Excess NEM was then removed by
desalting each of the six fractions using UHPLC. Desalted fractions were then completely reduced by
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incubation with 100mM TCEP at 55°C for 1hr, and subsequently alkylated by addition of 275µL of 200mM
IAM, and incubating for 2hrs at 37°C in the dark. The fractions were once again desalted using UHPLC,
lyophilized, and suspended in 0.5% formic acid for LC-MS/MS analyses. Using a 7 minute gradient, each
fraction was eluted through a 43mm HPLC-Chip/Q-TOF (Agilent Technologies), to allow complete
resolution of fully labeled peptides from those with incomplete alkylations. Data, collected in targeted and
auto MS/MS mode, was processed using molecular feature extraction software and matched to
theoretical sequences using MassHunter Bioconfirm Qual B.05 software (Agilent Technologies).
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Chapter 4 - Fluorescence Spectroscopy Using Solvatochromic Probes for
Investigation of Protein Structure, Function and Interactions
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4.1 Fluorescence spectroscopy in the study of biological systems
Fluorescence spectroscopy is a powerful tool for studying structure, dynamics and functional
interactions

of

biomacromolecules.

Unlike

high-resolution

structural

methods,

such

as

X-ray

crystallography and NMR, which provide a global picture of protein structure, fluorescence spectroscopy
utilizes a molecular probe to provide information about its surrounding environment. This probe, or
fluorophore, undergoes electronic excitation upon light absorption, and emits light of a characteristic
wavelength when it relaxes from its first singlet excited state to the ground state. The interaction of the
singlet excited state of a fluorescence probe with the local chemical environment can promote proton
transfer, form charge transfer complexes, cause exciplex formation, result in intersystem crossing to the
triplet state, promote resonance energy transfer, or cause reorientation of solvent and neighboring group
dipoles. All of these events influence measurable fluorescence parameters including emission and
excitation wavelengths, quantum yield, anisotropy, and fluorescence lifetime, thus providing invaluable
10

structural and dynamic information about the probe’s environment . In the context of biological sciences,
fluorescence measurements can provide a wealth of information on various molecular processes, like the
interactions of the probe and the surrounding solvent, rotational diffusion of macromolecules such as
proteins, distances between macromolecular regions, conformational changes, and binding interactions.
4.2 Protein fluorescence and the intrinsic fluorophore tryptophan
Using fluorescence spectroscopy to study proteins can be accomplished by utilizing fluorophores
that are already present in these biological macromolecules. These endogenous probes allow for
investigation of proteins without chemical perturbation caused by introduction of extrinsic probes. Of the
twenty encoded proteogenic amino acids, three have aromatic side chains that exhibit fluorescence, and
are considered intrinsic fluorophores. These are the side chains of phenylalanine (benzene), tyrosine
(phenol) and tryptophan (indole). Of these three, tryptophan (Trp, W) is most widely employed for the
study of protein structure, dynamics and interactions. Trp occurs only at about 1 mole% of all proteins,
10

more rarely than any other encoded proteogenic amino acid . This rarity facilitates interpretation of its
spectral data. Trp also absorbs light at lower energies than other aromatic amino acids, allowing for its
excitation independent of tyrosine (Tyr, Y) and phenylalanine (Phe, F). The unique photophysical
properties of Trp, such as sensitivity of its emission to the polarity of the local environment
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(solvatochromism), propensity for collisional fluorescence quenching, and high anisotropy have
contributed to its use as a probe in innumerable investigations of protein structure and function.
Additionally, Trp’s multiexponential intensity decay kinetics have been linked to the local secondary
structure of the polypeptide chain allowing for gleaning structural information about polypeptides in dilute
82

solutions via fluorescence lifetime measurements .
In spite of these useful spectral characteristics, Trp is far from being a perfect probe in context of
protein fluorescence spectroscopy. For example, despite its rare occurrence, most proteins contain more
than one Trp, inhibiting structural interpretation of fluorescence data due to inability to attribute spectral
signals to a specific residue. Although fluorescence lifetime decay analysis can be used to distinguish
between multiple fluorophores in distinct environments, most proteins containing just a single Trp display
multi-exponential decay kinetics, complicating the application of this approach. A further confounding
factor is the presence of two nearly isoenergetic excited states resulting from nearly perpendicular
1

1

electronic absorption transitions, La and Lb, in Trp (Figure 4.1).

1

Lb

N
H
1

La

Figure 4.1: Electronic absorption transition moments of indole10
1

1

While La is sensitive to the polarity of the environment, Lb is not, and emission can occur from either
state depending on the polarity of the surrounding cavity. However, it was shown that in all but most
1

extreme cases Trp emission in proteins occurs from La

83

. Additionally, both specific (H-Bonding) and

general solvent effects influence Trp emission, further complicating meaningful structural attribution of
spectral data. Studies of the interaction of Trp-containing proteins and nucleic acids also present a
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problem because nucleotides have a strong extinction coefficient in the region of tryptophan absorption
and thus contribute to a strong inner filter effect, that can be easily misinterpreted as quenching resulting
from intermolecular interactions

10, 84

. In summary, while the complexity of indole photophysics has

prompted detailed inquires into protein fluorescence using Trp as a probe, including studies of Trp
85

quantum yield as a function of local environment conducted in our laboratory , it has also limited
meaningful structural attribution of spectral data.
4.3 Tryptophan analogues for structure-conservative spectral enhancement of proteins
Expanding the spectroscopic utility of Trp in protein fluorescence has been widely pursued. While
Trp naturally occurs in proteins, some proteins lack a native Trp, or have more than one Trp. Thus, sitedirected mutagenesis can often be used to either introduce Trp at a desired site in a protein, or replace an
unwanted Trp by a residue with non-interfering spectral characteristics. However, such strategies can
often alter the structure/function of some proteins, and also do not address the shortcomings of Trp
photophysics, namely UV excitation, and complexity of solvent effects on its fluorescence.
One interesting approach of addressing the limitations of Trp as an intrinsic probe came from
investigations aimed at elucidating the pathway of Trp biosynthesis and its insertion into proteins during
translation. These studies showed that some nearly isosteric analogues of Trp can be biosynthetically
inserted into proteins by endogenous cellular machinery, with tryptophanyl tRNA-synthetase found to be
86

the key enzyme displaying substrate flexibility . Consequently, replacement of Trps with non-natural
tryptophan analogs with enhanced photophysical properties to address the issues of spectral overlap
while minimizing the effect on structure has been widely pursued

19, 87

. Since then, a number of Trp

analogs, each with distinct spectral advantages, were incorporated to create spectrally enhanced
alloproteins (Figure 4.2).
These analogs have been incorporated into a protein or peptide in a variety of ways:
biosynthetically via recombinant expression in a Trp auxotroph in the presence of the analog

87a-c

, by in

vitro transcription/translation using a nonsense suppressor tRNA chemically acylated with the analog
or by direct introduction of the analog during solid phase peptide synthesis

21, 87d

19, 88

,

. Although the structural

perturbations introduced by analog incorporation can vary depending on the specific protein and analog,
89

the majority of investigations have showed them to be minimal .
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Figure 4.2: Structures and spectral characteristics of Trp and its analogues. A. structures of tryptophan (1) 5-fluorotryptophan (2), 4-fluorotryptophan (3), 5-hydroxytryptophan (4), 7-azatryptophan (5),
their absorption (B), and fluorescence emission (C) spectra. Spectra of non-fluorescent 3 are omitted.
Spectra reproduced from reference 87e
As summarized by Ross et al.
vary.

87e

, spectral enhancements introduced by analog incorporations

While using fluorinated Trps allows for the possibility of studying proteins by

19

F-NMR, 4-

fluorotryptophan, 5-hydroxytryptophan (5HTP) and 7-azatryptophan all have desirable properties for
fluorescence enhancement (Figure 4.2 B,C).
4-fluorotryptophan is not fluorescent and is used to silence the signals from unwanted
tryptophans with minimal structure perturbation. 5HTP and 7-aza Trp exhibit red shifted absorption and
can be singled out in the presence of Trp using Red-edge excitation. However, significant absorption
envelope overlap with Trp still exists, barring fluorometric measurements at the absorption maxima of
these chromophores, resulting in decreased sensitivity when using these analogs. Also, the fluorescence
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emission spectra of 7-aza and 5-OH Trps significantly overlap that of Trp allowing for the possibility of
misattributing the fluorescence signal (Figure 4.2C). More recently, 4-azatryptophan was shown to be the
most red-shifted

90

of the isosteric tryptophan analogs described above. Having the largest Stokes shift of

all azatryptophans studied, this analog has a fluorescence emission maximum of 418nm, but still suffers
90

from a low quantum yield (0.077 as determined for 4-aza Indole) . Furthermore, the absorption profile of
4-aza Trp completely overlaps that of Trp, making it impossible to selectively excite this analog in the
presence of Trp.
Because many Trp analogs are isosteric or nearly isosteric with Trp, they are attractive choices
for conservative replacement of Trp for fluorescence enhancement. However, these analogs introduce
only a modest difference in spectral properties, and usually have poor quantum yields, barring sensitive
measurements.

Hence, there is still a need for probes with a more dramatic shift in fluorescence

excitation and emission maxima as well as an improved quantum yield.
4.4 Extrinsic solvatochromic probes to study proteins
A variety of extrinsic fluorescence probes, both engineered and natural, can be conjugated to
proteins to impart even more desirable fluorescent characteristics. Advances in organic synthesis
11

provided access to a plethora of such probes , ranging from the macromolecular green fluorescent
protein to small molecule organics such as Fluorescin or Dansyl. Among these, small molecule probes
that display the phenomenon of solvatochromism, and are amenable to site-specific incorporation into
proteins and peptides are of particular interest

14, 91

in the current context. This type of probe can be

thought of as a way to capitalize on the desirable aspects of Trp fluorescence (sensitivity to the
microenvironment), while minimizing its shortcomings (UV excitation and complex photophysics).
Analogous to the discussion of Trp analogues, the ability to incorporate these extrinsic fluorophores sitespecifically into a protein or peptide, as well as the size and charge of these probes are critical for
14

minimizing structural perturbation caused by their introduction . The principles guiding rational design of
solvatochromic probes with desirable photophysics, as well as the methods of their incorporation into
proteins and peptides are outlined in subsequent sections.
4.4.1 The phenomenon of solvatochromism
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The effects of the environment immediately surrounding a probe on its measurable fluorescence
characteristics are complex, and can include factors such as solvent polarity, rate of solvent relaxation,
and rigidity of the local environment among others. However, the effect of solvent polarity alone on
10

fluorescence emission of a given probe, partially described by the Lippert-Mataga equation , can be
instructive in the general understanding of fluorescence solvatochromism. The simplified Jablonski
diagram shown in Figure 4.3 shows a fluorophore whose dipole increases in magnitude upon excitation.
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Solvent relaxation, or reorientation of dipoles of the solvent sphere to accommodate the now larger dipole
of the probe, occurs on the picosecond timescale, and lowers the energy of the excited state while
simultaneously destabilizing the ground state. Return to the ground state by a fluorescence event results
in emission of photons of lower energy than those absorbed during excitation. Increasing solvent polarity
causes a greater degree of solvent relaxation, resulting in emission at progressively longer wavelengths.
Also a consequence of the narrowing of the energy gap caused by relaxation in progressively more polar
14

solvents is the increase in the rate of non-radiative decay (Knr) . As a result, many fluorophores exhibiting
classic solvatochromism have low fluorescence quantum yields (ϕ) in polar solvents.
While the Lippert-Mataga equation describes the relationship between fluorescence Stokes shifts
and general solvent polarity expressed in terms of its dielectric constant and refractive index, it neglects
specific solvent effects, such as hydrogen bonding. These effects can have a profound influence on the
photophysics characteristics of a probe, and depend on the structural properties of the fluorophore, which
in turn determine the mode of interaction of its excited state with the local environment (e.g. H-bonding of
solvent molecules with H-Bond donors or acceptor moieties on the probe). It is possible to gauge the
contribution of specific solvent effects on the fluorescence emission of a probe by fitting the spectral data
to an empirical function of solvent polarity. Several empirical solvent polarity scales were developed, with
the ET(30) single parameter scale

92

and the Catalán 3P multiparamater model

93

finding the most use in

the description of solvatochromic probes. The latter scale is particularly useful, as it allows delineating the
specific contributions of solvent acidity, basicity and general polarity/polarizability on the emission
properties of the probe.
Despite the existence of tools for gauging specific solvent effects, and myriad computational
studies describing specific excited state processes responsible for environment sensitivity of
fluorophores, probes that display classic solvatochromism with minimal contributions from specific solvent
effects are the most sought after. This is because a straightforward relationship between a measurable
fluorescence parameter and general polarity of the local environment allows description of a region of a
macromolecule to which the probe is bound with more certainty, even in the absence of knowledge of its
exact chemical makeup.
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4.4.2 Photophysical properties of solvatochromic probes
10

As shown in Figure 4.3, and described in the Lippert-Mataga equation (see p. 94), a probe
exhibiting solvatochromism must undergo a large change in the dipole moment upon excitation. In the
case of classic solvatochromism, the magnitude of the dipole increases upon excitation. This observation
allows for the rational design of such probes. The common wisdom for imparting solvatochromism to a
probe has been to append its aromatic core with flanking electron-donating and electron-withdrawing
substituents, causing increased charge separation upon excitation. This ubiquitous design feature is the
one constant among solvatochromic probes developed for monitoring biomolecular structure, interactions
and dynamics (Figure 4.4).
Besides the obvious requirement for strong solvatochromism to detect even subtle changes in the
microenvironment, these fluorophores must satisfy a larger set of photophysical requirements to be useful
for the study of biomolecules such as proteins and peptides. These include excitation at longer
wavelengths, a high absorption coefficient and quantum yield. Red-shifted excitation is required to allow
for selective monitoring of these extrinsic probes in the presence of endogenous fluorophores such as Trp
and Tyr. Excitation in the visible range of the spectrum is also desirable as it avoids the damaging effects
of UV light on biological macromolecules, and allows for using such probes for fluorescence microscopy.
The combination of a high extinction coefficient and quantum yield contribute to the overall brightness of a
fluorophore thus enabling ever more sensitive fluorescence measurements at lower substrate
concentrations. Despite significant advances in both organic synthesis and calculation methods that drive
the rational design of such probes, development of fluorophores that satisfy these requirements while
minimizing their steric bulk remains a considerable challenge.
It is important to note that the properties outlined above are just general goals in the development
of solvatochromic probes, and none of the fluorophores shown in Figure 4.4 can be considered ideal for
the investigation of all biomacromolecules. Instead, a given probe’s photophysical and steric
characteristics may make it suitable for one type of experiment and not another. This leads to some
confusion in describing a particular property of a fluorophore as beneficial or disadvantageous.
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For example, as mentioned earlier, many of the probes exhibiting solvatochromism have low quantum
yields in aqueous environments (Figure 4.4). From one perspective this is an advantage, because such
probes fluoresce brightly upon binding to proteins or membranes while remaining dark in bulk water,
making them useful as “stains” in fluorescence microscopy. In contrast, their low quantum yields in polar
environments prevent using these probes to accurately report on particularly polar or water exposed
protein domains.
The struggle in balancing desirable photophysics and sterics can be further illustrated by
following some trends in Figure 4.4. Prodan (N,N-dimethylamino-6-propionyl-2naphthylamine), with its
22

remarkable sensitivity to solvent polarity is one of the best examples of classical solvatochromic dyes ,
94

and has been widely popular for biological applications despite its UV absorption . The first attempt to
95

red-shift the absorption of this dye resulted in the derivative Anthradan , which absorbs in the visible, but
at the cost of a decreased extinction coefficient, reduced solvent sensitivity and added steric bulk. The
96

recently synthesized fluorene analogue of prodan, FR0 , represents significant improvements in both
absorption wavelength and solvent sensitivity. However, this dye has not yet been used for biological
investigations.
97

4-N,N-Dimethylaminophthalimide (4DMP) , is one of the first probes for polarity sensing, and
thus has found numerous applications in protein fluorescence. While it is prized for its solvent sensitivity
and small rigid structure, it still suffers from UV absorption and a low extinction coefficient. The extended
98

analogue, 6-N,N-dimethylamino-2,3-naphthalamide (6DMN) , was intended to improve on the properties
of 4DMP. However, modest improvements in its absorption coefficient and solvent sensitivity are offset by
lower

quantum

yields

and

added

steric

4-N,N-dimethylamino-1,8-naphthalamide (4DMN)

bulk.
99

In

contrast,

the

more

recently

developed

shows a quite significant improvement in absorption

wavelength. All dyes in this family are nearly nonfluorescent in water, limiting their applications in
monitoring interactions when the label has significant water exposure throughout the process.
The merocyanine family

100

represents the most desirable absorption characteristics, with marked

red-shifts and very large extinction coefficients. However, their large size and negligible solvent sensitivity
limits their applications as structural probes.
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1-Anilinonaphthalene-8-Sulfonic Acid (1,8-ANS)

101

, one the first solvatochromic dyes, has found

numerous applications in protein studies, and still remains relevant, but is virtually nonfluorescent in
aqueous media. Its structural analogue, the Dansyl fluorophore

102

has also found myriad applications in

protein fluorescence, but despite its improved quantum yield in polar media, it recently declined in
popularity due to its UV absorption and relatively weak solvatochromism.
The coumarin family of dyes

103

represents a valuable addition to the tool chest of solvatochromic

probes. Despite modest solvent sensitivity and UV excitation, coumarin derivatives display higher
quantum yields with increasing solvent polarity, effectively reversing the trend displayed by many other
solvatochromic dyes.
Nile Red

104

is a representative example of the phenoxazine family of dyes, combining red-shifted

absorption and high brightness. However, its solvent sensitivity is only moderate. A variety of its
derivatives have recently been developed for the labeling of biomolecules
analogues, such as APM

106

105

. Of these, the more compact

, are of particular interest as they minimize the structural perturbations caused

their introduction.
Dapoxyl®

107

shows remarkable solvatochromism together with high quantum yields and

extinction coefficients. However, its UV absorption has so far limited its biological applications in
biosensor development. Charged derivatives of this fluorophore, such as PyMPO

108

, can function as

alternatives for situations when a hydrophobic label can result in structural perturbation of the
macromolecule under study.
Nitrobenzoxadiazole (NBD) is another example of an early solvatochromic probe used for protein
labeling. Its advantages are its small, rigid structure and red-shifted absorption. While early experiments
using NBD to track ligand-induced conformational changes in a protein, have provided valuable insights
for future development of fluorescent biosensors

109

, its low solvent sensitivity limits its applications to

cases where the change in environment is particularly drastic.
The more recently developed probes, such as 3-methoxychromones (see 3MC-2)
dicyanomethylene-3-cyano-2,5-dyhodrofurans (DCDHF)

111

110

and 2-

, with their red-shifted absorption, high

brightness, and moderate to good solvatochromism, nicely illustrate the overall goals in the development
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of fluorescent polarity sensors. The latter is particularly prized because of its high photostability enabling
applications in single-molecule fluorescence.
Among the fluorophores available to date, Fluoroprobe

112

is the most sensitive to solvent polarity.

This bichromic dye exhibits charge transfer through space resulting in its unique sensitivity. However it
has not found any applications in biology because of its UV absorption, low extinction coefficient and
strong fluorescence quenching in polar media.
In summary, many fluorescent polarity sensors are currently in use, and as novel biological
experiments are becoming more sophisticated, the continued development of probes with improved
spectral characteristics is increasingly relevant. Importantly this is not a quest for “one fits all” solution, but
rather an attempt to continually increase the repertoire of tools available for today’s diverse biological
applications.
4.4.3 Incorporation of solvatochromic probes into proteins and peptides
In addition to meeting a set of photophysical and steric requirements, the introduction of
solvatochromic probes into proteins and peptides represents another important aspect of their
14

development . In fact, many fluorophores discussed in the previous section and depicted in Figure 4.4
found great utility in protein fluorescence because they were amenable to site-specific incorporation into
these macromolecules, while others remain theoretical curiosities because their incorporation methods
are nonexistent or underdeveloped.
There are many techniques for conjugating fluorophores onto proteins and peptides, but in the
context of polarity-sensing structural probes it is of interest to focus on the methods that enable maximal
attribution of fluorescence data to relevant structural, dynamic or binding events. Thus, methods that
introduce the fluorophore into a specific site in any desired region of a peptide or protein are the most
valuable. Harsh incorporation conditions are less than desirable as they can alter the structure or function
of the system under study. The common techniques for incorporation of solvatochromic dyes into proteins
or peptides can be broadly divided into two categories: (1) direct covalent modification and (2)
introduction of the fluorophore as an unnatural amino acid.
Direct covalent modification involves preparing a reactive derivative of the fluorophore for
conjugation with select endogenous functional groups present in polypeptides. The two most common
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approaches involve conjugating probes to amine groups of lysine residues (through the use of amineselective acylating functionalities, such as O-succinimidyl esters) or to thiol groups of cysteine residues
(via thiol-selective electrophiles such as α-halocarbonyls or maleimides). Of the two, cysteine conjugation
is the preferred method, as this amino acid occurs much more rarely in proteins and its nucleophilic thiol
13

functionality is reactive under milder conditions . Although site-directed mutagenesis allows engineering
of either cysteine or lysine into virtually any desired site in protein, natural occurrence of these residues
necessitates mutations at multiple sites prior to labeling, which raises the probability of altering the
structure and function of the protein. Another drawback of direct covalent modification is low water
solubility of solvatochromic fluorophores, which often necessitates addition of an organic co-solvent
during labeling reactions. This can cause denaturation of the protein, requiring the costly and not always
successful refolding procedure. Finally, because this type of labeling attaches the fluorophore via an
amino acid side chain, the probe is not held as closely to the protein backbone. This additional
conformational freedom complicates attribution of spectral data to characteristics of a specific site.
Engineering solvatochromic fluorophores into amino acid derivatives overcomes many of the
challenges associated with direct covalent modification. In fact, many of the probes listed in Figure 4.4
have been made into amino-acid derivatives, which greatly expanded their utility as polypeptide probes.
Perhaps the most notable example of this is the synthesis of the amino acid Aladan, bearing the Prodan
side chain, almost simultaneously by two research groups

113

, which resulted in high-profile publications

describing the use of this polarity-sensor on protein systems. Introduction of these unnatural amino acids
can be accomplished at the peptide level during SPPS, at the protein level through suppression of the
17

amber stop codon during translation , or semi synthetically through expressed protein ligation (EPL)

15 16

of an SPPS assembled peptide bearing the unnatural amino acid with a protein fragment.
In SPPS, unnatural amino acids bearing solvatochromic side chains could be incorporated
directly via their corresponding Nα-Fmoc or -Boc derivative. Protection of reactive side-chains during
SPPS makes it possible to incorporate virtually any unnatural amino acids, although some of their
functionalities, such in the case of 4-DMP and 6-DMN
products during standard chain elongation procedures.
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, can cause the formation of undesired side

	
  
At the protein level, incorporating an unnatural amino acid bearing a solvatochromic side chain is
possible by chemically acylating it onto a modified tRNA which inserts it into the protein in response to an
17

unused stop codon (TAG) during recombinant protein expression . This technique is extremely difficult to
implement, often suffers low incorporation yields, results in truncated recombinant proteins, and is not
necessarily compatible with any unnatural amino acids

13-14

.

The ability to incorporate solvatochromic probes during SPPS can also be extended to the protein
level through protein semi synthesis by EPL. Assembled by SPPS, peptides bearing the probe can be
ligated to the C- or N-terminus of a recombinantly synthesized protein fragment. EPL relies on a
chemoselective transthioesterification of a thioester and an N-terminal cysteine residue, which upon an S
to N intramolecular acyl shift results in a native peptide bond. N-terminal ligation occurs between a
fluorophore-bearing peptide thioester prepared by SPPS and a recombinant protein fragment whose Nterminal cysteine residue is exposed by proteolytic cleavage. Alternatively, the probe-bearing peptide with
an N-terminal cysteine prepared by SPPS is ligated with a recombinant protein fragment which is
modified into a C-terminal thioester by using a defective intein-based approach

115

. Although EPL is a

powerful technique to extend the chemical flexibility of SPPS to protein systems, probe attachment using
this strategy is limited to within approximately 40 residues from the C- or N- termini because of
decreasing SPPS efficiency with increasing peptide length.
4.5 Converting a tryptophan analogue to a sensitive extrinsic probe: oxidative coupling reaction of 5hydroxytryptophan (5HTP) with amines
The unique reactivity of one Trp analogue, 5HTP, suggests a possibility of creating a probe with
both desirable photophysics and a built-in incorporation method. 5HI, the side chain moiety of 5HTP, is
known to react with primary amines under mild, biologically compatible conditions to produce a
fluorescent adduct 6H-oxazolo[4,5-e]indole (Figure 4.5). As this adduct extends the conjugation along the
1

solvent sensitive La transition of indole, it also has the potential to exhibit solvatochromism. Furthermore,
since straightforward methods for incorporating 5HTP into peptides via standard Fmoc-SPPS without
21

requiring side chain protection , and into proteins through selective pressure incorporation

20

exist, this

chemistry can be used to create a fluorophore capable of site-specifically labeling these macromolecules.
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This oxidative coupling reaction, first discovered during the investigation of an antitumor drug
ellipticine

116

18

, has been employed in quantifying 5-hydroxyindoles by fluorescence detection , and has
19

been recently used in preparing fluorescent cyclic peptides . Using benzylamine as the primary amine
nucleophile in a reaction with 5-hydroxyindole, produces 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI), a
fluorophore with significantly red-shifted excitation and emission (Ex. 345nm, Em. 465nm), a dramatically
4

improved quantum yield (0.54 compared to 0.17 for Trp) and a high extinction coefficient (1.54x10 vs.
3

-1

-1 19

6.57x10 cm M ) . Although its solvatochromism is yet to be determined, these initial findings suggest
that PHOXI can be a valuable addition to the tool chest of existing solvent sensitive probes, having
absorption and emission characteristics that are distinct from intrinsic protein fluorophores, and a built-in
method of its incorporation into proteins and peptides.

Figure 4.5: Oxidative Coupling of 5-hydroxindole with primary amines
4.6 Project Research Objectives
The overall goal of this project is to develop the PHOXI fluorophore as a solvent-sensitive probe
for the study of protein and peptide systems, by evaluating both its photophysics and site-specific
incorporation capability. First, to investigate the solvatochromism of PHOXI, the core fluorophore is
synthesized and its absorption, steady-state as well as time-resolved fluorescence properties are studied
in a series of solvents spanning the dielectric continuum. The extent and nature of its solvent sensitivity is
evaluated by the application of the Lippert-Mataga equation and the Catalán 3P empirical solvent model.
Density functional theory calculations are be employed to investigate the structure of PHOXI and the
nature of its photophysical behavior.
Site-specific incorporation of this fluorophore by derivatization of peptides containing 5HTP is also
19

evaluated. The first and only use of this reaction on a polypeptide system was reported in 2009 , where it
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was used to modify 5HTP containing peptides. Although this report sets an important precedent of the
viability of this reaction to introduce the PHOXI fluorophore into biomolecules, it lacks the necessary
evidence of selectivity and biocompatibility of this derivatization because the 5-HTP peptides were
prepared using in vitro translation in minute (sub µM concentration in ~10µL) quantities, only allowing for
determination of reaction products by mass spectrometry without chromatographic separation. Thus, the
authors’ claim, based on mass spectrometric evidence, that only the desired products are formed during
this derivatization, is premature. It is also inconsistent with the proposed mechanism for this reaction

117

,

which suggests that unwanted products can arise from attack of the p-quinoneiminemethide intermediate
by nucleophiles other than the intended benzylamine (Figure 5.1).
The current work focuses on using model peptides to evaluate the PHOXI derivatization strategy
by monitoring reaction products using HPLC, allowing for optimization of reaction conditions.
Recombinant synthesis of 5HTP containing model proteins by modified selective-pressure incorporation
methods is also attempted to demonstrate the viability of the PHOXI incorporation strategy at the protein
level.
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Chapter 5 - Evaluation of 5HTP Derivatization in Peptide Systems and Structural
and Solvatochromic Description of PHOXI
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5.1 Background: Oxidative coupling of 5-hydroxyindole with primary amines
As discussed in section 4.3, tryptophan analogues have been widely pursued for the spectral
enhancement of proteins. These structure-conservative probes are easily introduced into proteins in
response to native Trp codons by selective pressure incorporation, resulting in site-specific labeling
without the use of difficult and time-consuming strategies used for introduction of extrinsic solvatochromic
probes (EPL semi synthesis, and nonsense codon suppression). However, the spectral enhancement
afforded by these analogues is modest, and is easily eclipsed by that of rationally designed
solvatochromic fluorophores. One of the Trp analogues, 5HTP, owing to its reactivity with primary amines
under mild conditions to produce a new fluorophore with improved properties, offers an opportunity to
capitalize on hassle-free selective pressure incorporation, while achieving desirable photophysics
comparable to extrinsic polarity sensing probes.
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Figure 5.1: Oxidation products of 5HI under biomimetic conditions
5-hydroxyindole (5HI), the side chain of 5HTP, has long been known to undergo oxidation under
mild conditions

118

. A study investigating the oxidation products of 5-hydroxytryptamine (the

neurotransmitter serotonin, which bears a 5HI functionality) under biomimetic conditions using H2O2peroxidase, identified a number of oligomeric products (Figure 5.1)
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118a

. The nature of these oxidation

	
  
products suggests that the reaction proceeds through a highly reactive intermediate that is susceptible to
capture by nucleophiles at the 4 position.
5HI oxidation in the presence of external nucleophiles was first encountered during investigations
of 9-hydroxy derivatives of the plant alkaloid ellipticine, which contains a 5HI moiety within its structure.
5HI was found to be oxidized to the p-quinoneiminemethide, a potent electrophilic species

119

(Figure

5.2A). This intermediate was found to undergo regiospecific Michael type additions by a variety of
oxygen, sulfur and nitrogen nucleophiles, which were found to add specifically to the C4 indolic position)
(Figure 5.2B)

116

. Further investigations used the amino group of aliphatic amino acids as the nucleophile

to trap the p-quinoneiminemethide intermediate (Figure 5.2C)

120

, however, the structural assignment of

these amino acid adducts was later called into question, and was revised to the annulated oxazolo
derivatives, the fluorescent properties of which are exploited in later analytical studies (figure 5.2D)
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Figure 5.2: Reactions of 9-hydroxyellipticium with nucleophiles under oxidative conditions
The generality of this reaction with various primary amine nucleophiles was then explored on a
model system 6-hydroxyindole-2-carboxylate, and a mechanism for oxazole formation was proposed
(Figure 5.3 shows the mechanism as it applies to 5HI)

117

. While benzylamine gave the highest yield of

oxazole (61%), it is interesting to note that reaction with ethanolamine produced the unsubstituted
oxazole, attributed to deacylation during or after oxazole formation.
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Figure 5.3: Mechanism of oxazole formation during oxidation of 5HI in the presence of primary
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In the early 1990’s analytical chemistry researchers reported on the determination of 5-HIs
(namely the neurotransmitter serotonin (5-OH tryptamine) and related metabolites) by spectrofluorometric
detection of novel oxazole containing fluorophores formed during oxidation of 5HIs in the presence of
benzylamine

or

3,4-dimethoxybenzylamine

18a

.

The

fluorophore

produced

upon

benzylamine

derivatization, 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI) (Figure 5.4), was reported to have fluorescence
emission maximum at 481nm with excitation at 350nm. These spectral characteristics are a significant
improvement over Trp analogues, suggesting that this derivatization reaction can be of use for spectrally
enhancing peptides and proteins. The reaction proved to be substrate specific, as no fluorescence was
observed in a reaction with unhydroxylated tryptophan and biological phenols, and was conducted in
aqueous buffer with dimethylsulfoxide (DMSO) as the oxidizing agent. It was also shown that
substitutions on the aryl ring of the amine reagent did not affect fluorescence properties of the resulting
oxazoles to a great extent, with the 3,4-dimethoxybenzyl derivative having λem=474nm. Later analytical
studies applied this method to increasingly complex biological systems further attesting to the
chemoselectivity of this reaction

18b, 122

. These later investigations used the mild oxidizing agent potassium

hexacyanoferrate (K3[Fe(CN)6]), which is too weak to oxidize any endogenous functional groups present
in peptides and proteins except for 5-hydroxyindole. Also, unlike DMSO, the salt K3[Fe(CN)6] is not
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expected to result in protein denaturation. The focus of these studies, however, was to develop a robust
analytical method for detection of 5HI-containing neurotransmitters and related metabolites, not to apply
this chemistry for spectral enhancement of macromolecules. Thus, the authors were concerned with
optimizing reaction conditions to attain maximal fluorescence emission, without regard to yield or any
nonfluorescent byproducts that may have formed.
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Figure 5.4: Fluorogenic oxidative coupling of 5HI (1) and benzylamine. Initial oxidation forms p-quinoneiminemethide (2) which is highly reactive to nucleophiles at position 4. Nucleophilic attack by benzylamine at this position, followed by oxidation to the imine, a 1,5 hydride shift, and ring closing yields (3)
2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI).
19

The first and only use of this reaction on a polypeptide system was reported in 2009 , where it
was used to modify 5-hydroxytryptophan containing peptides. The authors used benzylamine and
4-biotynyl-benzylamine in an intermolecular reaction with 5-HTP containing peptides to successfully
synthesize (PHOXI) modified peptides. Encouraged by the results of these intermolecular reactions, the
authors then included both the benzylamine moiety and the 5-HTP residue onto the same peptide and
were able to produce a cyclized peptide upon oxidation with K3[Fe(CN)6]. These investigators also varied
the residues adjacent to 5HTP in the peptide sequence to investigate the proclivity of canonical amino
acids to introduce undesired side products during derivatization. Of all proteogenic amino acids, only
cysteine was found to give an undesired side product, presumed to be resultant from the attack of
cysteinyl sulfhydryl group on the reactive intermediate formed during oxidation of 5HTP. The investigators
also reported the quantum yield (0.54), fluorescence emission maximum (461nm), and absorption spectra
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4

-1

-1

(λmax=326nm, ε=1.54 x 10 cm M ) of PHOXI for the first time. However, because all of the peptides in
this study were produced by in-vitro ribosomal synthesis, which is done on a very small scale	
   (sub µM
concentration in ~10µL), no chromatographic separation was performed on reaction mixtures. Instead the
authors rely solely on MALDI-TOF mass spectrometry and fluorescence measurements to corroborate
successful derivatization results. Using these techniques, it is impossible to determine the efficiency of
the derivatization, or ascertain the absence of undesirable side products, the existence of which is likely
according to earlier studies highlighting the reactivity of the p-quinoneiminemethide intermediate. A recent
investigation of products, yields and kinetics of reactions of 5HI and other proquinoidal analytes
(catechols) with benzylamine and related nucleophiles further calls into question the absence of side
19

products reported by Yamagishi et al. , with only 30% yield of PHOXI reported when 5HI is reacted with
benzylamine under idealized conditions

123

.

While the goal set by Yamagishi et al.

19

was to develop a novel way of producing cyclic peptides,

the few spectral properties of PHOXI reported in the study, namely high brightness (through a
combination of extinction coefficient and quantum yield), and visible range fluorescence emission, serve
as an important precedent for employing this strategy for spectral enhancement of peptides and proteins.
The fact that 5HTP can be readily introduced into proteins by selective pressure incorporation

17, 87a

and

21

into peptides during standard Fmoc SPPS , combined with evidence of chemoselectivity and
biocompatibility of its derivatization to produce PHOXI provided by both the aforementioned analytical
chemistry studies

18, 122

19

, and Yamagishi et al. , suggests that this chemistry can be viable for spectral

enhancement of these biomacromolecules.
This project focuses on investigating the photophysics of PHOXI, and describes its
solvatochromism, which was found to be comparable to established polarity sensing probes, for the first
time. The viability of PHOXI derivatization is also investigated using model 5HTP containing peptides, and
ways to minimize formation of undesired byproducts are identified, by chromatographic separation and
monitoring of derivatization reactions. Recombinant production of 5HTP-containing proteins with the goal
of demonstrating PHOXI derivatization at the protein level is also attempted.
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5.2 Results and Discussion
Two 5HTP containing peptides, tryptophanyl-5-hydroxytryptophan, and TrpZip2 (SWT-5HTPENGKWTWK) were used to evaluate PHOXI derivatization conditions. Monitoring reaction products by
HPLC allowed for identification of factors that minimize undesired product formation during the PHOXI
derivatization procedure. Fluorescence and MS analysis confirmed the spectral enhancement and the
identity of PHOXI derivatized peptides. The β-hairpin structured peptide TrpZip2 was also used to
ascertain the extent of structural perturbation caused by introduction of PHOXI using circular dichroism
(CD) spectroscopy.
PHOXI was successfully synthesized from 5HI and benzylamine by adapting a previously
published procedure

117

, and its spectroscopic properties (fluorescence emission, excitation, quantum

yields and lifetimes) were investigated in six neat solvents spanning the dielectric continuum. PHOXI’s
fluorescence emission maximum was found to be strongly dependent on the polarity of the surrounding
media. Its solvatochromism was further investigated by analysis of spectral data using the Lippert-Mataga
equation, and Catalán 3P empirical solvent scales. PHOXI’s structure and origins of its solvatochromism
were further investigated by density functional theory (DFT) calculations.
Attempts to create more structurally conservative analogs of PHOXI, guided by the fact that 6hydroxyindole-2-carboxylate has been shown to react with amines of the general structure R-CH2-NH2 to
produce oxazoles of the general structure of PHOXI, with R replacing the phenyl ring

117

. Specifically,

analogs of PHOXI where the phenyl ring is replaced with H were investigated to minimize the size of this
fluorophore and thus the structural perturbation caused by its introduction into peptides and proteins.
There are precedents for using methylamine

124

or ethanolamine

117

as nucleophiles, albeit in organic

media, to produce these unsubstituted PHOXI analogs. In contrast to benzylamine, attempts to use these
reagents to label peptides in a biologically compatible manner were not met with success (data not
shown). While methylamine derivatization did not produce any fluorescent products contrary to a patent
claim

124

the reaction with ethanolamine produced 3 fluorescent products, two of which were difficult to

separate by RP-HPLC. The formation of these three fluorescent adducts is consistent with previous
reports

121

, but due to the difficulty in resolving them, derivatization with ethanolamine was not pursued

further.

78	
  

Biosynthetic incorporation of 5HTP into glutathione-S-transferase (GST) and horse skeletal
muscle myoglobin (HMb) with the intent of demonstrating PHOXI derivatization at the protein level was
also attempted. 5HTP incorporation into GST was achieved at a very low level (data not shown), and
although subsequent PHOXI derivatization did produce a characteristic PHOXI fluorescence signature,
the sample was not homogeneous due to the presence of 4 Trps in GST and low 5HTP incorporation
efficiency. Attempts at expression of the simpler 2 Trp containing HMb using two different expression
systems were not met with success. In view of the fact that others have successfully accomplished 5HTP
incorporation into proteins

87a-c

, these efforts were not pursued further, with the primary focus on

demonstrating the viability of PHOXI derivatization on peptidic systems, and thorough description of its
photophysical properties.
5.2.1 Biosynthetic Incorporation of 5HTP into proteins
Initial attempts to incorporate 5HTP were done using glutathione-S-transferase (GST) as model
protein substrate. Although this 4 Trp-containing homodimeric protein is a less than ideal system to test
the PHOXI derivatization strategy, it was chosen because it remains soluble and expresses to high levels
in E. coli. Furthermore, a plasmid vector (pET41b+) encoding GST is commercially available eliminating
the need for cloning. Although traditional approaches to Trp analogue incorporation rely on using Trp
auxotrophic hosts, these bacterial strains are not commercially available. Instead, an alternative
approach

125

, which uses an inhibitor of aromatic amino acid biosynthesis N-phosphomethylglycine

(glyphosate) was used. Briefly, bacterial hosts are first grown to log phase in rich media, and then
transferred to minimal media (devoid of Trp) containing glyphosate, 5HTP, as well as supplements of Tyr
and Phe, prior to induction of protein expression. 6x His tagged GST produced under 5HTP incorporation
conditions was then purified by Ni-NTA, and incorporation of 5HTP was checked by subjecting it to
digestion with trypsin, and MS analysis of resulting peptides against theoretical values. This analysis
proved inconclusive, as observed m/z values corresponding to 5HTP containing peptides were nearly
identical to other predicted tryptic fragments that do not contain Trp. Subjecting these peptides to MS/MS
analysis was also inconclusive, as most fragment ions observed did not contain Trp. Nevertheless,
recombinantly produced GST was subjected to PHOXI derivatization conditions. Subsequent
fluorescence analysis did show characteristic PHOXI fluorescence, but the spectrum was complex and
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the signal was very weak, suggesting very low 5HTP incorporation levels and protein sample
heterogeneity (Data not shown). Because GST contains 4 Trps with varying degrees of solvent exposure
this result is hardly surprising.
Horse skeletal muscle myoglobin (HMb), containing one surface-exposed and one buried Trp, was then
chosen as a simpler protein model system. It was envisioned that that once 5HTP is incorporated into
both sites, PHOXI derivatization would occur only at the surface exposed site allowing for spectroscopic
differentiation of the two Trps. The coding sequence for HMb was successfully subcloned into the same
pET41b+ vector, replacing the coding sequence for GST. While expression of HMb under nonincorporation conditions produced high levels of both soluble and insoluble protein (which had to be
refolded and reconstituted with hemin) with a characteristic red color, no expression was observed under
incorporation conditions. Low expression levels (or no expression) under analog incorporation conditions
were also reported by a number of groups utilizing the pET expression system and are summarized by
20

Ross et al . These issues are attributed to the fact that this system requires the synthesis of T7 RNA
polymerase upon induction of expression, which in turn transcribes the protein of interest. Because
expression is induced under incorporation conditions, T7 RNA polymerase, which contains 17 Trps, can
be rendered non-functional, resulting in no expression and no incorporation. To mitigate this problem, the
use of the pQE expression system, which does not require the synthesis of new proteins upon induction
of expression was attempted. The coding gene for HMb was again subcloned into the pQE60 vector. New
E. coli host strains M15 and SG13009 were made competent and successfully transformed with
pQE60HMb. However, no protein expression was observed even under non-incorporation conditions.
Due to these persistent problems, 5HTP incorporation into proteins was no longer pursued.
5.2.2 Evaluation of PHOXI derivatization of model peptides
WWOH readily reacted with benzylamine in borate buffer, pH 8.0, in the presence of 2mM
K3[Fe(CN)6] to produce fluorescent PHOXI adduct within 10 minutes at room temperature. After
separation of reaction products by HPLC, a major peak with high absorption at 326nm, characteristic of
PHOXI was isolated. This peak was isolated, and its identity confirmed by mass spectrometry as NH2Trp-PHOXI-OH (Figure 5.5). Fluorescence spectrum of this product was consistent with free PHOXI
emission and excitation, further corroborating its identity as a PHOXI peptide adduct.

80	
  

Figure 5.5: Mass spectra of Tryptophanyl-5-hydroxytryptophan before and after PHOXI derivatization. (A) NH2-Trp-5HTP-OH Calculated [M+H] 407.17; observed [M+H] 407.18 (B) NH2-Trp-PHOXI-OH
N Calculated [M+H] 508.19; observed [M+H] 508.15
HPLC monitoring of reaction products observed during the PHOXI derivatization of WWOH under
varying conditions is shown in Figure 5.6A, and the fluorescence spectrum of NH2-Trp-PHOXI-OH
showing characteristic PHOXI visible emission with λmax=451nm and a marked increase in intensity
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relative to NH2-Trp-5HTP-OH is shown in figure 5.6B. The PHOXI emission increase is due to synergistic
3

-1

effects of a high extinction coefficient (4.5 × 10 M cm

-1

as measured in 0.5M Borate pH 8.0) and

quantum yield (0.54) of PHOXI.
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Figure 5.6: A. HPLC monitoring (A), and fluorescence enhancement of NH2-Trp-5HTP-OH (B), upon
derivatization with PHOXI. All reactions are carried out in 250mM Borate buffer pH 8.0 for 10min, with
the following additions: ■ – 10μM(+) or 100μM(++) NH2-Trp-5HTP-OH, ▲ – 2mM K3[Fe(CN)6],● – 0.5M
benzylamine. Peaks are identified as NH2-Trp-5HTP-OH(1), benzylamine(2) and NH2-Trp-PHOXI-OH(3).
Conducting the oxidation reaction in the absence of benzylamine (Figure 5.6A, lower left)
produces a number of products. This is consistent with the highly reactive nature of pquinoneiminemethide intermediate 2 (Figure 5.4) that is formed upon oxidation of 5HTP, and with
previous studies of oxidation of 5-hydroxyindole

118a

showing a complex mixture of oligomeric products

resulting from nucleophilic capture of intermediate 2 at the 4 position. However, in the presence of large
excess of benzylamine, the fluorescent PHOXI adduct is the major product of the reaction (Figure 5.6A,
upper right).
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Figure 5.7: HPLC Monitoring of TrpZip2(5HTP) before (A) and after (B) PHOXI derivatization.Reaction carried out in 250mM Borate buffer pH 8.0, with 10μM TrpZip2, 2mM K3[Fe(CN)6], and 0.5M benzylamine for 10min. Asterisk indicates desired PHOXI adduct.

Figure 5.8: MALDI-TOF spectra of TrpZip2(5HTP) before and after PHOXI derivatization. (A)
SWT-5HTP-ENGKWTWK Calculated [M+H] 1624.75; observed [M+H] 1624.83 (B) SWT-PHOXI-ENGKWTWK Calculated [M+H] 1726.72; observed [M+H] 1726.92.
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Derivatization of TrpZip2 also afforded the desired PHOXI labeled adduct, albeit with formation of
a greater number of byproducts (Figure 5.7). Despite the presence of a number of nonfluorescent
oxidation products, the PHOXI adduct was readily separable by HPLC, and its identity was confirmed by
MALDI-TOF MS (Figure 5.8).
The concentration of 5HTP-bearing peptide had a profound effect on the number and amount of
undesired byproducts produced during derivatization. Undesired byproducts are produced when the
peptide concentration is increased from 10 to 100µM (figure 5.6A, lower right). These products appear at
the same retention time as those formed during the oxidation of WWOH in the absence of benzylamine.
This finding suggests that at higher concentrations unwanted products result from capture of intermediate
2 by another molecule of peptide. It was found that generally keeping the 5HTP-bearing peptide at
concentration of 20µM or below eliminates the majority of these byproducts. Some unwanted products,
however, are insensitive to peptide concentration (note minor peaks in Figure 5.6A, upper right).
Presumably, these arise from intramolecular capture of intermediate 2 by reactive groups on the peptide
itself. The fact that the amount of these substrate concentration-independent products varies with the
sequence of the 5HTP peptide gives further credence to this assumption, as peptides with differing
sequence can have varying amounts of nucleophilic groups in proximity to the 5HTP reaction center.
Although it was impossible to eliminate these byproducts by altering reaction conditions, the desired
PHOXI derivatized product was easily identifiable and separable by HPLC for both WWOH and a TrpZip2.
To ensure that PHOXI derivatization conditions are selective for 5HTP only, a control reaction
was also conducted using the peptide Aβ-40, which does not contain 5HTP but has all canonical
amino acids except for cysteine, tryptophan and proline (Figure 5.9). This peptide was found to not be
affected by reaction conditions used for PHOXI derivatization.
Derivatization of these two 5HTP-containing model peptides shows that the PHOXI fluorophore
can be introduced by a quick and selective oxidation reaction in aqueous buffer in the presence of
benzylamine. While unintended reaction byproducts can be observed during derivatization of 5HTP
bearing peptides, the Aβ-40 peptide, which is devoid of 5HTP, is completely unaffected by the reaction
conditions, attesting to the selectivity of this reaction. Because the byproducts present during the
oxidation of 5HTP peptides in presence of benzylamine are the same as those formed during oxidation of
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5HTP peptides in its absence, it is reasonable to conclude that these species are formed by capture of
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the proposed reaction intermediate 2 by nucleophiles other than the intended benzylamine.
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Figure 5.9: HPLC monitoring of PHOXI derivatization of Aβ-40 (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV). All reactions are carried out in 250mM Borate buffer pH 8.0 for 10min, with the
following additions: ■ – 20μM Aβ-40, ▲ – 2mM K3[Fe(CN)6], ● – 0.5M benzylamine. (A) Derivatization
Reagents only (B) Aβ-40 peptide only; (C) Derivatization Reagents and Aβ-40 peptide; (D) Chromatogram
C with A subtracted.
Although the presence of these side products is less than desirable in the context of peptide
labeling, their formation is consistent with the proposed reaction mechanism
documented in previous reports

118a, 123

117

and is additionally

. However, even with this inherent limitation, PHOXI derivatized

products are easily visualized and isolated by RP-HPLC for both peptides tested. Overall, the oxidative
coupling reaction of 5HTP peptides to produce PHOXI offers a fast and easy protocol for labeling of
peptides: the reaction is assembled from just three components in aqueous buffer, and is completed in 10
minutes or less. Furthermore, because PHOXI is assembled in-situ using water-miscible benzylamine, it
avoids the need for inclusion of harsh organic solvents during labeling reactions, an otherwise necessary
step during labeling with many common organic fluorophores, which suffer from low water solubility.
Taken together, these above findings suggest that PHOXI labeled peptides are easily accessed
through oxidation of 5HTP peptides in the presence of benzylamine and subsequent RP-HPLC
purification. The PHOXI fluorophore is introduced site-specifically at the 5HTP site, and because it only
modifies the indole side chain of 5HTP, the PHOXI label is introduced in a conformationally restricted
manner, being linked to the peptide backbone through a single methylene bridge. For a probe to be useful
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in characterization of the microenvironment, this short and rigid tether offers clear advantages over other
common fluorophore attachment strategies (such as through side chain and terminal amine groups, as
well as cysteine thiol groups), which result in longer flexible tethers and greater degrees of freedom.
The PHOXI labeling strategy is applicable to wide variety of biomolecules, primarily due to the
ease of introduction of 5HTP into peptides and proteins. For example, 5HTP is easily incorporated as its
21

Fmoc derivative during SPPS using standard protocols , incorporated into proteins in response to a Trp
20

codon during recombinant expression in a Trp auxotrophic host , or introduced into a desired site by
19

means of nonsense suppression . Furthermore, recent work utilizing PHOXI as a fluorescent linker for
peptide immobilization suggests that Fmoc protected tryptophanyl PHOXI derivative can be introduced
during SPPS as well

126

.

Applying this chemistry to 5HTP protein substrates is expected to present challenges associated
with separation of the correctly PHOXI labeled protein from undesired byproducts. While RP-HPLC
purification may prove sufficient for some protein substrates, inadequate resolution and unwanted protein
denaturation in HPLC buffers are among the expected challenges. However, a workaround solution
based on substrate flexibility of this fluorogenic coupling reaction can be envisioned. Several groups
reported that benzylamines substituted at one or more of the phenyl positions still react with 5HTP to form
fluorescent adducts analogous to PHOXI

18a, 19

. One of these reaction variants included the introduction of
19

biotynyl benzylamine upon oxidation of a 5HTP peptide substrate . Because unwanted byproducts arise
from the capture of the reactive intermediates by nucleophiles other than the intended benzylamine, using
benzylamines functionalized with non-nucleophilic affinity tags, can facilitate the separation of correctly
labeled protein products through affinity purification.
5.2.3 Photophysical and solvatochromic properties of PHOXI
Spectroscopic properties of PHOXI derivatized peptides
Figure 5.10 shows the fluorescence emission and excitation spectra of WWOH (A) and TrpZip2 (B)
before and after PHOX derivatization. The excitation maxima of PHOXI analogues of WWOH and TrpZip2,
were found to be 336nm and 341nm respectively. These wavelengths are outside of the Trp absorption
envelope allowing for selective excitation of PHOXI in presence of Trp. PHOXI and Trp also form a FRET
pair. We have computed the critical Förster distance, R0= 23.5Å for the PHOXI-Trp system. This value
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falls into the useful range for distance measurements in the context of biological macromolecules.
Evidence of FRET can be seen in the emission spectra of PHOXI bearing peptides upon excitation at
280nm (Figure 5.10, dashed lines).
Excitation

Emission

Normalized Fluorescence

1

A

1

0
1

0
1

B

0
240

NH2-Trp-5HTP-OH
NH2-Trp-PHOX-OH

TrpZip2(5HTP)
TrpZip2(PHOX)

280

320

360

0
300

400

500

600

Wavelength (nm)

Figure 5.10: Normalized fluorescence excitation and emission of NH2-Trp-5HTP-OH vs.
NH2-Trp-PHOXI-OH (A) and TrpZip2(5HTP) vs. TrpZip2(PHOXI) (B). Emission spectra for PHOXI
peptides are shown either with excitation at 336nm (solid black), or 280nm (dashed black).
The structural perturbation caused by PHOXI substitution was also probed by obtaining CD
spectra of TrpZip2 bearing either 5HTP or PHOXI at position 4 (Figure 5.11). TrpZip2 is engineered to
adopt a β-hairpin structure, stabilized by stacking interaction of two pairs of tryptophan residues

127

.

Although one of these structure-inducing Trps is replaced by the bulkier PHOXI, the PHOXI derivative of
TrpZip2 still retains some of its β-hairpin structure. As shown in Figure 5.11, the positive elipticity at
230nm of PHOX-bearing TrpZip2 at 25°C is approximately the same as that of 5HTP-bearing TrpZip2 at
80°C.
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Figure 5.11: Effect of PHOXI derivatization on β-hairpin stability of TrpZip2 probed by CD. A. 3D
structure of TrpZip2 stabilized by Trp interactions (RCSB PDB entry 1LE1 rendered using UCSF Chimera). B. CD spectra of TrpZip2(5HTP) (blue) at 25°, 65° and 80°C, and of TrpZip2(PHOXI)(red) at 25°, 65°
and 80°C.
Solvatochromism
To glean the utility of PHOXI as a spectroscopic probe capable of providing structural information,
it was synthesized from 5HI and benzylamine, and its spectroscopic properties in six different neat
solvents spanning a range of polarity were investigated. The results are summarized in Table 5.1, and
absorption and emission spectra are shown in Figure 5.12.
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Table 5.1: Spectroscopic properties of PHOXI in neat solvents
-1

Solvent

λabs(nm)

λex (nm)

λem (nm)

γStokes(cm )

φF (±10%)

Lifetime (ns)

Cyclohexane

331

331

372

3330

0.6

1.69

Toluene

322

336

390

5415

0.69

1.91

1,4-Dioxane

333

335

409

5580

0.78

2.51

Acetonitrile

320

332

427

7831

0.72

3.29

Methanol

325

336

437

7886

0.55

4.06

Water

321

336

459

9366

0.54

5.71

B

Cyclohexane
Toluene
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Normalized Absorbance

Normalized Fluorescence Intensity
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R2 = 0.98
m = -11584
SP = 0.79SPP + 0.12SB + 0.09SA
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m = -13738
SP = 0.69SPP + 0.13SB + 0.18SA
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Figure 5.12: Spectroscopic properties of PHOXI in solvents of varying polarity. (A) absorption,
offset; (B) normalized fluorescence emission ; (C) Multi-parameter fits of PHOXI and Prodan (constructed
using previously published Prodan emission data128) fluorescence maxima to a global solvent parameter,
SP, as defined in the Catalán 3P model93
PHOXI fluorescence emission maxima were found to be very sensitive to solvent, exhibiting redshifted emission with increasing solvent polarity. PHOXI emission redshifts by 87nm in water relative to
cyclohexane, suggesting that PHOXI fluorescence emission is highly sensitive to the environment.
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Vibrational structure is present in the emission spectra of PHOXI in non-polar solvents cyclohexane and
toluene, but not in more polar solvents (Figure 5.12). While PHOXI absorption maxima did not vary
significantly (spanning a range of only 10nm), the quantum yields were found to vary, but remained high
(between 0.54 and 0.78) in all solvents studied. Fluorescence lifetimes exhibited single exponential decay
(Figure 5.13) and varied between 1.69ns (cyclohexane) and 5.71ns (water), increasing with solvent
polarity. Succeptibitily of PHOXI to photodegradation was also tested by exposure to UV light and
monitoring the decrease of its fluorescence intensity at the maximum over time. The experimental set up
96

was identical to that used to probe photostability of Prodan and its analogue FR0 . After 1 hour, a
solution of PHOXI in toluene had 72% of its fluorescence intesity remaining, compared to 10% for
Prodan

	
  

96

96

and 76% for FR0 .
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Figure 5.13: Fluorescence lifetime decay curves for PHOXI in six neat solvents. Decay (red) and
instrument response (blue) curves are plotted on a log scale. The fitted functions and residuals sre shown
in green. All fits were done using single exponentials, except cyclohexane and 1,4-dioxane, which were
fitted using 3 exponentials, and only the lifetime of highest amplitude is shown. The low amplitude
lifetimes in these cases are considered artifacts introduced by the broad instrument response function.
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Table 5.2 Solvent parameters used for analysis of PHOXI solvatochromism
Solvent
SPP
SB
SA
ε
Δf
Cyclohexane
0.557
0.073
0
2.02
-0.0017
Toluene
0.655
0.128
0
2.38
0.0132
1,4Dioxane
0.701
0.444
0
2.25
0.0245
Acetonitrile
0.895
0.286
0
37.5
0.3054
Methanol
0.857
0.545
0.605
32.7
0.3074
Water
0.962
0.025
1.062
80.1
0.3200
93a
93b
SPP, SB and SA are Catalán’s empirical solvent parameters of polarity/polarizability , basicity and
93b
acidity respectively, ε is the dielectric constant, Δf is orientation polarizability function as described in
the Lippert-Mataga equation.
To better understand the solvatochromic nature of PHOXI, its spectral shifts were fitted to linear
functions of a generalized solvent parameter, SP, using empirical solvent parameters described by
93

Catalán et al. , and supplying proportionality constants (See Table 5.2 for a list of solvent parameters
used in the analysis). Figure 5.12C shows the dependence of PHOXI emission maxima on SP; an
analogous fit of the emission of Prodan in the same six solvents is included for comparison (constructed
using previously published Prodan emission data

128

2

). For PHOXI, a good linear fit (R =0.98) was

achieved when SP = 0.79SPP + 0.12SB + 0.09SA, where SPP is solvent polarity-polarizability, SB is
solvent basicity, and SA is solvent acidity, while for Prodan the best fit is realized when SP = 0.69SPP +
0.13SB + 0.18SA. Notably, almost all of the variance in PHOXI spectral shifts is explained by SPP, with
only minor contributions from acidity and basicity. In fact, a single parameter fit to SPP alone gives
2

R =0.94, suggesting that the dipolar nature of the PHOXI excited state is primarily responsible for the
observed solvatochromism. In contrast, Prodan fluorescence emission displays roughly twice the
sensitivity to solvent acidity. For PHOXI, the minor contributions of acidity and basicity are not surprising,
since it contains both an acidic group (the indolic NH) and a basic group (the oxazole O).
Variations in PHOXI’s quantum yields, fluorescence lifetimes, and rates of radiative (Γ) and nonradiative (knr) decay were also analyzed using the Catalán 3P model, and are shown in Figure 5.14. Γ and
knr were computed from measured quantum yields (Φ) and lifetimes (τ) according to equations:
Γ=
𝑘!" =

	
  

Φ
τ

1−Φ
τ
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Figure 5.14: Analysis of PHOXI lifetimes, quantum yields, and rates of radiative and non-radiative decay using the Catalán 3P model.
Both lifetimes and quantum yield increase with solvent polarity, with excellent correlation
observed for the lifetime fits. The majority of the variation in lifetimes is explained by general solvent
polarity, but solvent acidity was also found to have a non-negligible contribution. Interestingly, as with
solvatochromic coumarin probes, PHOXI’s quantum yields increase with solvent polarity, opposing the
otherwise general trend observed for polarity sensing probes

14

(See Figure 4.4, and discussion in section

4.4.2). This polarity trend is offset by a sizable contribution by solvent acidity, suggesting a possible
quenching mechanism via accepting an H-bond. The poor correlation for the quantum yield fits is
explained in part by the uncertainty of the measurements (+/-10%). Finally both Γ and knr decrease with
increasing solvent polarity, with minor contributions from SB and SA. Once again the less than perfect fits
are explained by uncertainties in the quantum yield measurements, which are used to calculate Γ and knr.
The change between the ground and excited state dipole moments of PHOXI can be ascertained
10

from its spectral shifts in solvents of differing polarity by means of the Lippert-Mataga equation :
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γ!"#$%! =   

2
(Δµμ)! Δf + constant
hca!

where γstokes is the Stokes shift expressed as energy, h is Plank’s constant, c is the speed of light, a is the
Onsanger radius of the solvent cavity occupied by the fluorophore, Δµ is the difference in dipole moments
between the ground and excited states, and Δf is the orientation polarizability function defined as

Δf =   

ε−1
n! − 1
−    !
2ε + 1 2n + 1

where ε is dielectric constant, and n is the refractive index of the solvent.
Because this equation does not take into account the contributions of specific solvent
interactions, we included the SA term into a multi parameter fit along with Δf, mirroring the analysis of
PRODAN solvatochromism by Catalán

128

. Regression analysis of PHOXI Stokes shifts affords:

γStokes = 15035(0.63Δf + 0.37SA) + 4205 with R2= 0.90
Accounting for the variance in Stokes shifts caused by SA in the above equation, and substituting into the
Lippert-Mataga equation gives:

9402  hca!
Δµμ =   
2
Assuming an Onsanger cavity radius of 4.94Å, (taken as half of the distance between C4 of the phenyl
substituent and the indolic N, which are the furthest heavy atoms flanking the PHOXI conjugated system,
as ascertained from its geometry optimized ground state structure derived by DFT), the transition dipole
moment of PHOXI is 10.6D, showing evidence of highly-dipolar excited state.
5.2.4 DFT analysis of PHOXI structure and photophysics
Geometry optimization of the ground state structure of PHOXI shows that, unexpectedly, it adopts
a planar confirmation in all of the solvents studied, with ground state energy decreasing with increasing
solvent polarity. Time-dependent DFT (TD-DFT) calculations identified the solvent-sensitive, lowest
st

energy transition (346.17nm in cyclohexane and 348.31nm in water) as leading to the 1 excited state. In
both cases, it corresponds to a HOMO to LUMO π-π* transition.
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5.3 Conclusion and future directions
In addition to a reliable way for incorporation into specific sites of a biomolecule, this investigation
of the photophysics of PHOXI revealed that it has many desirable characteristics of a sensitive
fluorescent reporter tag and reporter of the peptide/protein microenvironment. The fluorescence emission
spectrum of PHOXI lies in the visible (λEM = 459nm in water), and its high quantum yield (0.54) and
absorption extinction coefficient contribute to its brightness. Consistent with the above properties, PHOXI
peptide adducts display visible fluorescence emission and an approximately 5-fold increase in brightness
relative to unmodified 5HTP peptides. In the context of biological investigations, visible emission enables
fluorescence microscopy analyses, while high fluorophore brightness allows analyses at lower substrate
concentrations.
PHOXI absorption also shows a significant overlap with the Trp emission envelope, allowing
PHOXI to act as a FRET acceptor to Trp. The calculated critical Förster distance of 23.5Å for this pair falls
within the usable range (20-80Å) for distance measurements for biological macromolecules. Since Trp is
an intrinsic fluorophore, this furthers PHOXI’s utility to provide structural information, and enables it to be
used in binding assays for Trp containing binding partners. Also of significance here is the fact that
PHOXI absorption and excitation wavelengths are outside of the Trp absorption envelope, allowing for
selective excitation of PHOXI in the presence of Trp. As seen in Figure 5.10, when H2N-Trp-PHOXI-OH is
irradiated with 336nm light, only PHOXI emission is observed, while excitation at 280nm yields both Trp
emission and PHOXI emission by way of FRET.
High sensitivity of PHOXI’s fluorescence emission, lifetimes, and quantum yields to the polarity of
the surrounding media allows it to be used as a sensitive reporter of the local microenvironment – greatly
increasing the amount of structural, dynamics, and binding assay data that can be extracted from
experiments using this probe. It was found that PHOXI’s spectral emission maximum redshifts by 87nm
when the solvent is changed from the nonpolar cyclohexane to water. Probes exhibiting this degree of
solvatochromism are highly sought after, and many are rationally designed to impart this property.
A comparison of PHOXI’s photophysical properties to other solvatochromic probes with
absorption below 400nm is shown in Table 5.3. It is important to reiterate that none of these fluorophores
have the perfect photophysics for any given biological investigation, and none, except for PHOXI, have an
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intrinsic method of site-specific biosynthetic incorporation. The degree of PHOXI’s solvatochromism is
comparable to that of Prodan, 6DMN, 4DMP, and Dansyl probes. The extinction coefficient of PHOXI is
close to the average of the probes listed, and its high quantum yield in polar solvents makes it a great
alternative to probes such as Fluoroprobe, 6DMN and 4DMP, which exhibit low quantum yields in polar
solvents.
Table 5.3: Comparison of PHOXI with solvatochromic probes with absorption <400nm
Polar solvent
Apolar solvent
(MeOH)
(Toluene)
λAbs(nm)
εmax
λFluo
QY
λFluo
QY
ΔνFluo
Dye
Ref.
-1
(MeOH)
(MeOH) (nm)
(%)
(nm)
(%)
(cm )
Fluoroprobe
FR0
Dapoxyl®
derivatives
Prodan

308
396

a

12000
43000

695
570

b

<0.1
19

373
361

28000
18400

584
498

39
51

b

476
434

46
98

6620
5500

112
96

457
417

86
55

4760
3900

107
22

6DMN
382
8000
589
1.2
491
21
3390
98
c
b
b
4DMP
396
6500
534
12
457
62
3160
97
Dansyl
derivatives
335
4600
526
49
471
81
2220
102
PHOXI
326
15400
437
55
390
69
2760
λAbs, absorption maximum; εmax absorption coefficient; λFluo fluorescence emission maximum; QY, quantum
a
b
c
yield. Data in cyclohexane, Tetrahydrofuran, 1,4-dioxane.
The extinction coefficients, quantum yields, and degree of solvatochromism of PHOXI is
comparable to that of Prodan, one of the most successful solvatochromic dyes in the realm of biological
investigations. While PHOXI exhibits moderately lower bathochromic shifts with increasing solvent
polarity than Prodan, its sensitivity to specific solvent acidity effects is approximately half that of Prodan.
This more straightforward relationship will help to better ascertain the polarity of protein cavities. Although
the amino acid analogue of Prodan, Aladan, was recently reported to be an efficient reporter of protein
electrostatics in Shaker potassium channel and Kir2.1 proteins

113a

, its sensitivity to H-bond donors

complicates the attribution of such data to polarity of protein cavities. In fact, Catalán has cautioned of
attributing such spectral data to general polarity effects

128

, theorizing that the high polarity of the heme

binding pocket in apomyoglobin as ascertained from Prodan fluorescence

129

can also be attributable to

specific interactions with nearby NH sites.
Furthermore, the molecular structure of PHOXI does not resemble the traditional scaffold of
electron donor/acceptor moieties flanking an aromatic system that is the hallmark of other solvatochromic
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dyes. This elucidates an alternative approach in rational design of such probes. Earlier studies show that
oxidation of 5HI in the presence of a series of primary amines, produces a number of structural analogues
of PHOXI, which bear other alkyl and aryl groups in place of its phenyl substituent

18a, 19, 117

. Furthermore,

the closely related 6-hydroxyindole displays the same pattern of reactivity as 5HI, except that amines add
to the 7 indolic position, resulting in a series of 8H-oxazolo[5,4-g]indoles

117

. This opens up a possibility of

investigating a whole library of PHOXI-like compounds as potential fluorophores, and further honing their
photophysical properties.
In conclusion, this work represents a valuable addition to the field of peptide and protein
solvatochromic fluorophore development. Not only does PHOXI itself make a valuable addition to the
arsenal of polarity sensing probes because of its photophysics and built-in incorporation ability, but its
unique structure suggest alternative routes for the design of such molecules. Finally, although the
chemistry of 5HI oxidation in the presence of amines has long been known, this project describes its
application to fluorophore development for the first time. Thus, this body of knowledge of the reactivity of
5HI and related systems can now be tapped to develop a collection of PHOXI analogues that can
combine fluorescence with affinity purification tags, or have even more desirable spectral properties.
5.4 Materials and Methods
Materials.
NH2-Trp-5HTP-OH (98.3% purity) and human Aβ-40 peptide (purity 98%) were purchased from
Lifetein (Hillsborough, NJ); 5HTP-TrpZip2 (SWT-5HTP-ENGKWTWK) (99% purity) was custom
synthesized by Peptide 2.0 (Chantily, VA). The purity of all peptides was confirmed by HPLC prior to use.
Benzylamine (99%) was purchased from Acros Organics (Geel, Belgium), and distilled before use. 5hydroxyindole (97%) was purchased from Aldrich (St. Louis, MO) and purified by sublimation prior to use.
Preparation

of

2-phenyl-6H-oxazolo[4,5-e]indole

(PHOXI).

2-phenyl-6H-oxazolo[4,5-e]indole

was

prepared from 5-hydroxyindole and benzylamine by adapting a procedure described by Boger et al

117

.

Briefly, 0.375mmol 5HI and 0.45mmol benzylamine were dissolved in 40mL of dry dichloromethane and
cooled to 0°C under N2. 1.75g of activated MnO2 was then added and the reaction was allowed to warm
to room temperature. After 4 hours, the reaction mixture was filtered through celite, and solvent was
evaporated under reduced pressure. The residue containing the fluorescent product (Rf = 0.41 (DCM))
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was purified by silica gel flash column chromatography eluted with 10% ethyl acetate in petroleum ether.
PHOXI 1H-NMR (CDCl3, 400MHz): δ 8.51 (br, 1H), δ 8.31-8.32 (m, 2H), δ7.52-7.53 (m, 3H), δ7.38-7.43
(dd, 2H), δ7.36(br,1H), δ7.04 (br, 1H). The 1H-NMR data are consistent with previously published reports
for 2-phenyl-6H-oxazolo[4,5-e]indole
5.4.1 Recombinant Expression and selective pressure incorporation of 5HTP into proteins
GST
The plasmid vector pET41b+ coding for GST was transformed into E. Coli BL-21(DE3)
expression hosts by heat shock, and positive transformants were selected by plating on LB plates
containing 30mg/L Kanamycin. For analogue incorporation, cells were initially grown in “rich media”
(10g/L N-Z Amine, 5g/L NaCl, 10g/L Tryptone, 4g/L Glucose, 30mg/L Kanamycin) at 37°C and 250rpm
until an OD600 ~0.7 was reached. The cells were then harvested from culture by gentle centrifugation
(5min, 4000 x g, 37°C) and resuspended in prewarmed “minimal media” (50 mM Na2HPO4, 50 mM
KH2PO4, 2 g/L D-glucose, 2 g/L NH4Cl, 20 mM Sodium Citrate, 1 x 5052

130

, 1g/L glyphosate, 60mg/L

5HTP, 60mg/mL Phe, 60mg/mL Tyr, 30mg/L Kanamycin). After a 30 min incubation at 37°C and 250rpm
to exhaust remaining tryptophan stores, expression was induced by addition of 1mM isopropyl β-D-1thiogalactopyranoside (IPTG). Total cell protein extracts were prepared at 1, 2, 3, 4, and 12hours after
induction and analyzed by SDS-PAGE. Maximum production of GST was at 3 hours post induction (~10%
of total cell protein). The cells were harvested by centrifugation (10min, 10000 x g, 4°C), and the pellets
immediately stored at -80°C for subsequent purification. 6 x His Tag purification was conducted under
native conditions using Qiagen Ni-NTA agarose following the manufacturer’s batch purification protocol,
and followed by SDS-PAGE.
Horse Skeletal Muscle Myoglobin
The amino acid sequence for this HMb, (Uniport ID: P68082), was back-translated using codons
otpitimized for E. coli expression, and appended with nucleotide sequences introducing an N-terminal
NdeI site, and a C-terminal 6 x His sequence and XhoI site. This construct was synthesized by IDT DNA
and delivered in the pIDTBlue cloning vecor. pIDTBlue(HMb) was then used to transform BL21 competent
cells by heat shock, and positive transformants were selected by plating on LB-kanamycin plates.
Plasmid DNA was extracted from overnight LB cultures using QiagenMiniprep kit, according to the
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manufacturer’s protocol. Both pIDTBlue(HMb) and pET41b+ were subjected to double restriction
endonuclease digestion with NdeI and XhoI according to the manufacter’s protocol (New England
Biolabs(NEB)). Digested DNA was separated on a 1% agarose gel, and the bands corresponding to HMb
and linearized pET41b+ were excised. DNA was extracted from the gel using the Agilent Strataprep kit
according to the manufacturer’s protocol. The vector backbone was dephosphorylated with arctic alkaline
phosphatase (NEB) prior to overnight ligation with HMb insert with T4 DNA ligase(NEB) according to the
manufacturer’s protocol. Aliquots of the ligation reaction were used to transform BL-21(DE3) host cells,
and positive clones were selected by plating on LB-kanamycin plates, and sent for sequencing to confirm
correct orientation and reading frame of the plasmid construct (pET41b+HMb).
Expression was performed as described for GST. For expression using the pQE system, the coding
sequence was now appended with NcoI and BglII sites, and supplied as a double stranded gBlock from
IDT DNA. The insert and the vector pQE60 were subjected to double digestion by NcoI and BglII (NEB),
and subjected to the same purification, dephosphorylation, and ligation procedure as described for
pET41b+HMb assembly. Heat shock competent cells were prepared from E. coli strains M15 and
SG13009 (Qiagen) according to the manufacturer’s protocol and were transformed with ligation mixtures.
Selection of positive clones was done by plating on LB-ampicillin plates. Positive clones from both M15
and SG13009 strains were confirmed by sequencing.
5.4.2 PHOXI derivatization of peptides
For optimization of derivatization conditions, 10-100µM of 5HTP-containing or control peptide was
dissolved in 0.5M borate buffer, pH 8.0 in the presence or absence of 0.5M benzylamine in an HPLC
microvial. The reactions were initiated by addition of K3[Fe(CN)6] to a final concentration of 2mM. After 10
minutes, the reactions were stopped and the products analyzed by direct injection onto a Series 200
HPLC system (Perkin Elmer, Waltham, MA) equipped with an XBridge C18 4.5 X 150mm column (Waters
Corporation, Milford, MA). The products were separated by eluting with a linear gradient of Buffer A (0.1%
TFA in water) and buffer B (0.1% TFA in Acetonitrile) at a flow rate of 1mL/min as follows: 5 min 100%
Buffer A, 2 minutes increasing to 20% Buffer B, 20 min increasing to 40% buffer B. The products and
unreacted starting materials were visualized by a UV-Vis flow-cell detector at 220nm (peptide amide
bonds), 280nm (Tryptophan and/or 5HTP) and 326nm (PHOXI).
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Product peaks with appreciable

	
  
absorption at 326nm were manually collected, lyophilized and subjected to mass spectrometry to confirm
identity of PHOXI derivatized products. Lyophilized NH2-TRP-5HTP-OH derivatization products were
dissolved in 50% Acetonitrile containing 0.1% formic acid and analyzed by direct infusion onto an Agilent
6220 ESI-TOF mass spectrometer. TrpZip2 derivatization products were analyzed using a MALDI-LTQ
XL

orbitrap

mass

spectrometer

(ThermoFisher

Scientific,

Waltham,

MA)

using

α-Cyano-4-

hydroxycinnamic acid as matrix.
5.4.3 Spectroscopic Measurements
Absorbance measurements.
Background corrected absorption spectra were recorded on a Lambda 650 UV−vis
spectrophotometer (Perkin Elmer, Walnut Creek, CA) with a 2 nm slit width, 1 cm path length, and 1 nm
3

-1

-1

3

-1

-1

interval. Extinction coefficients of Trp (5.69 × 10 M cm ) 5HTP (4.5 × 10 M cm ) and PHOXI (1.54 ×
4

-1

-1

10 M cm ) were used to determine concentrations.
Steady-State Fluorescence Emission Measurements
Fluorescence emission spectra of PHOXI derivatized peptides in water, and of PHOXI in neat
solvents were recorded on a Fluorolog 3 model FL-1000 (Horiba Jobin Yvon, Edison, NJ) fluorometer. For
PHOXI derivatized peptides, emission spectra were recorded with an excitation wavelength of 280 nm
(Trp) and 336nm (PHOXI). For quantum yield measurements of PHOXI in neat solvents, the excitation
wavelength used corresponded to maximum excitation of PHOXI in each solvent (332nm for acetonitrile;
336nm for 1,4-dioxane, methanol, toluene and water), except for cyclohexane, where 322nm had to be
used to obtain a complete emission profile. For all fluorescence measurements, the step size was 1nm,
the integration time was set to 0.1 s. The slit width was 2nm and matched that of absorption
spectrophotometer. All concentrations were < 0.01 mM to avoid inner filter effects.
Quantum Yield Determination.
Aqueous quinine sulfate (QY = 0.54)
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and harmane (QY = 0.83)
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in 0.1 M sulfuric acid were used as

quantum yield standards. PHOXI quantum yields in six neat solvents were determined by the method
described by Williams et al.
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Briefly, the quantum yield of the two quantum yield standards are first

determined via reference against each other to ensure confidence in quantum yields measured for the
unknown. The integrated fluorescence intensity of each fluorophore is determined from emission spectra
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at several fluorophore concentrations, all less than 0.01 mM, to avoid the inner filter effect. The integrated
intensity is plotted as a function of the measured absorbance at each concentration. A linear fit is
calculated, ensuring that the fit line runs through the origin. Obviously, the goodness-of-fit should be close
to unity. The slope of the fit is the gradient, G, used in calculation of the quantum yield, QY:

  𝑄𝑌! = 𝑄𝑌!"

𝐺!
𝐺!"

𝑛!!
!
𝑛!"

where the subscript, st, signifies the quantities for the quantum yield standard, and x are the quantities for
the fluorophore of unknown quantum yield. n is the refractive index for each solution: n = 1.333 for water,
n = 1.334 for 0.1 M sulfuric acid, n = 1.497 for toluene, n = 1.427 for cyclohexane, n = 1.331 for methanol,
n = 1.344 for acetonitrile, n = 1.422 for 1,4-dioxane.
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Trp-PHOXI Förster Distance Calculation.
10

The Förster distance was calculated using the equation :
!

!!

𝑅! = 0.2108 𝑘 𝛷!"# 𝑛 𝐽

!
!

Where R0 is the critical Förster distance in angstroms, k is the dipole orientation factor and was set to 2/3
(assuming rotation of molecular dipoles is much faster than FRET rate), ΦTrp is the quantum yield of Trp in
water (0.14), n is the refractive index of the medium taken as 1.4 for biological macromolecules, and J is
-1

-1

4

the overlap integral in units of cm M nm , defined as follows:
!

𝐹!"# (𝜆)𝜀!"#$% (𝜆)𝜆! 𝑑𝜆

𝐽=
!

Where FTrp(λ) is the fluorescence emission of Trp normalized to unity, and εPHOXI(λ) is the normalized
-1

-1

absorption spectrum of PHOXI scaled to its extinction coefficient ε326nm = 15400 cm M .
Time-Resolved Fluorescence Lifetime Decay Measurements.
Fluorescence lifetime measurements of PHOXI in six neat solvents were carried out on a
commercial instrument that employs a laser diode excitation source with a broad (1.47 ns) instrument
response function (Horiba Jobin Yvon, Edison, NJ). Excitation at 340nm was achieved with a NanoLED
source (<1ns pulse). An experimental instrument response function, necessary for proper deconvolution,
was collected from scattered light from an aqueous casein solution at 340nm.
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PHOXI Photodegradation Assays:
A 0.33µM solution of PHOXI in either toluene or water in a 50µL quartz microcuvette was
illuminated by a Xenon lamp of a Fluorolog spectrofluorimeter at 336nm for 5000s. The lamp power at the
cuvette was 8.5mW and the illumination area was 3mm H x 2mmW.

Emission and excitation

monochromator slits were set to 8nm. During illumination the fluorescence at the maximum (459nm for
Water, 390nm for Toluene) was recorded at 1s intervals. The percentile fraction of residual fluorescence
signal after an hour of illumination was recorded.
Fluorescence Lifetime Decay Analysis:
The lifetimes for decays collected on the diode instrument were determined by iterative
convolution using the vendor-provided decay analysis software, DAS6. Details of this method are
described by Eisenberg and Juszczak.
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Circular Dichroism of PHOXI and 5HTP containing TrpZip2 peptide.
A Chirascan CD spectrophotometer (Applied Photophysics,) equipped with a sample temperature
controller unit was used to obtain CD spectra of 25µM aqueous solutions of TrpZip2 peptides bearing
either 5HTP or PHOXI in place of Trp 4. For each peptide, spectra were recorded at 25°C, 65°C and
80°C.
5.4.4 DFT calculations
Calculations were submitted with the help of Dr. Azaria Eisenberg. Gaussian 09 software was
used for ab initio quantum mechanical calculations. The ground-state structure was optimized using the
B3LYP density functional theory method and 6-311G* basis set, with an ultrafine grid. The polarizable
continuum method with implicit solvents were used to allow for the solvent effects, and the structure was
checked for imaginary frequencies to insure that it was not in a transition state. Excited state calculations
were done with the same B3LYP method and basis set. Calculations were done on the BOB system at
the CUNY High Performance Computing Center.
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